[
  {
    "bcr_patient_uuid": "9583C10B-B21A-4863-98FA-61E735E64EA5",
    "patient_ID": "TCGA.2E.A9G8",
    "bcr_drug_barcode": "TCGA-2E-A9G8-D59815",
    "bcr_drug_uuid": "A4823502-4CBD-4B1E-AEC1-8F2354DAAA6F",
    "form_completion_date": "2014-5-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 580,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9583C10B-B21A-4863-98FA-61E735E64EA5",
    "patient_ID": "TCGA.2E.A9G8",
    "bcr_drug_barcode": "TCGA-2E-A9G8-D59816",
    "bcr_drug_uuid": "B2A9F3C5-EC2F-4E11-A5C9-B9CD9C7BE1FA",
    "form_completion_date": "2014-5-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 610,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16AC4341-CF8F-45E2-B90B-2D12D5F74A59",
    "patient_ID": "TCGA.5B.A90C",
    "bcr_drug_barcode": "TCGA-5B-A90C-D58621",
    "bcr_drug_uuid": "30F8962E-59E4-42C2-AC7C-736C39EDEF0D",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 682,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 883,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16AC4341-CF8F-45E2-B90B-2D12D5F74A59",
    "patient_ID": "TCGA.5B.A90C",
    "bcr_drug_barcode": "TCGA-5B-A90C-D58622",
    "bcr_drug_uuid": "1F05373F-27B1-44D4-ADF1-32CBBBA75C88",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 682,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 883,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8751429B-4A11-451E-B978-DC9E9DB0EB36",
    "patient_ID": "TCGA.5S.A9Q8",
    "bcr_drug_barcode": "TCGA-5S-A9Q8-D64498",
    "bcr_drug_uuid": "51AE8C2B-147A-4785-B895-44D3C74EAF2A",
    "form_completion_date": "2014-9-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8751429B-4A11-451E-B978-DC9E9DB0EB36",
    "patient_ID": "TCGA.5S.A9Q8",
    "bcr_drug_barcode": "TCGA-5S-A9Q8-D64499",
    "bcr_drug_uuid": "C3D2C1D7-A802-4380-AE62-B29E2614F2BB",
    "form_completion_date": "2014-9-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8432401d-799f-4f2f-b536-e79e1e8be064",
    "patient_ID": "TCGA.A5.A0G3",
    "bcr_drug_barcode": "TCGA-A5-A0G3-D3064",
    "bcr_drug_uuid": "0c74c478-7909-45f2-989f-2442ebd29551",
    "form_completion_date": "2010-9-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 487,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 590
  },
  {
    "bcr_patient_uuid": "8432401d-799f-4f2f-b536-e79e1e8be064",
    "patient_ID": "TCGA.A5.A0G3",
    "bcr_drug_barcode": "TCGA-A5-A0G3-D3067",
    "bcr_drug_uuid": "e4ba8c1b-c01d-4897-925f-d10b42b29f28",
    "form_completion_date": "2010-9-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 487,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "71fed998-8fac-4e6b-b38a-22c83e05e958",
    "patient_ID": "TCGA.A5.A0GA",
    "bcr_drug_barcode": "TCGA-A5-A0GA-D3148",
    "bcr_drug_uuid": "9658c911-2106-4b8f-9441-e5ce11892ca0",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "[IU]/MG",
    "drug_dose": 470,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2820
  },
  {
    "bcr_patient_uuid": "71fed998-8fac-4e6b-b38a-22c83e05e958",
    "patient_ID": "TCGA.A5.A0GA",
    "bcr_drug_barcode": "TCGA-A5-A0GA-D3150",
    "bcr_drug_uuid": "035bc2a1-a8c9-42df-994d-ab737a1a24bb",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "[IU]/MG",
    "drug_dose": 348,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2088
  },
  {
    "bcr_patient_uuid": "71fed998-8fac-4e6b-b38a-22c83e05e958",
    "patient_ID": "TCGA.A5.A0GA",
    "bcr_drug_barcode": "TCGA-A5-A0GA-D3152",
    "bcr_drug_uuid": "4b2ef5d4-e9cc-415f-ac10-74a083276002",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 300,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "94817e78-78f5-4556-9394-610df65605e2",
    "patient_ID": "TCGA.A5.A0GJ",
    "bcr_drug_barcode": "TCGA-A5-A0GJ-D5084",
    "bcr_drug_uuid": "140aa32f-fa70-4d3b-9dc1-e382713dcb62",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3560
  },
  {
    "bcr_patient_uuid": "94817e78-78f5-4556-9394-610df65605e2",
    "patient_ID": "TCGA.A5.A0GJ",
    "bcr_drug_barcode": "TCGA-A5-A0GJ-D5083",
    "bcr_drug_uuid": "c438c2aa-2888-4f3e-ad69-01526619697e",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1460
  },
  {
    "bcr_patient_uuid": "39609d3c-f5d3-4bc4-b356-1403c6dd1cb5",
    "patient_ID": "TCGA.A5.A0R6",
    "bcr_drug_barcode": "TCGA-A5-A0R6-D6810",
    "bcr_drug_uuid": "6134df03-db34-406b-9b85-e7605941a59d",
    "form_completion_date": "2011-1-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 295,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1475
  },
  {
    "bcr_patient_uuid": "23489245-48d7-4f19-8a42-e23b1181412b",
    "patient_ID": "TCGA.A5.A0VQ",
    "bcr_drug_barcode": "TCGA-A5-A0VQ-D3376",
    "bcr_drug_uuid": "e2bdd433-9356-4ec4-86a5-96378b96589a",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1110
  },
  {
    "bcr_patient_uuid": "23489245-48d7-4f19-8a42-e23b1181412b",
    "patient_ID": "TCGA.A5.A0VQ",
    "bcr_drug_barcode": "TCGA-A5-A0VQ-D3378",
    "bcr_drug_uuid": "a6458d3a-b619-441d-b988-8294ffb98afa",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 680
  },
  {
    "bcr_patient_uuid": "5c3f826c-b447-457d-a90e-715bad3c7118",
    "patient_ID": "TCGA.A5.A1OG",
    "bcr_drug_barcode": "TCGA-A5-A1OG-D14464",
    "bcr_drug_uuid": "2F94DC95-172E-4D8E-8A67-DC4CDBBD342E",
    "form_completion_date": "2011-8-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 417
  },
  {
    "bcr_patient_uuid": "5c3f826c-b447-457d-a90e-715bad3c7118",
    "patient_ID": "TCGA.A5.A1OG",
    "bcr_drug_barcode": "TCGA-A5-A1OG-D14465",
    "bcr_drug_uuid": "43E577E4-CF6B-4C02-BC5A-95F0D6B97D34",
    "form_completion_date": "2011-8-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2505
  },
  {
    "bcr_patient_uuid": "5c3f826c-b447-457d-a90e-715bad3c7118",
    "patient_ID": "TCGA.A5.A1OG",
    "bcr_drug_barcode": "TCGA-A5-A1OG-D14466",
    "bcr_drug_uuid": "DD9A9130-FB9C-483D-A329-0226963D04E7",
    "form_completion_date": "2011-8-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "9BCE44A2-DCEE-4D1A-A522-C2BCB9A8E025",
    "patient_ID": "TCGA.A5.A1OH",
    "bcr_drug_barcode": "TCGA-A5-A1OH-D34162",
    "bcr_drug_uuid": "F76236DB-DF2C-4184-B035-5CFE33C5FE59",
    "form_completion_date": "2012-8-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2fe46394-cfc5-44bb-81a9-e438a0126f5b",
    "patient_ID": "TCGA.A5.A1OK",
    "bcr_drug_barcode": "TCGA-A5-A1OK-D14472",
    "bcr_drug_uuid": "6AED6CCE-F567-416F-9840-39BA6D75E115",
    "form_completion_date": "2011-8-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3612
  },
  {
    "bcr_patient_uuid": "2fe46394-cfc5-44bb-81a9-e438a0126f5b",
    "patient_ID": "TCGA.A5.A1OK",
    "bcr_drug_barcode": "TCGA-A5-A1OK-D14473",
    "bcr_drug_uuid": "E070191B-E5FA-4DF8-8218-C0A3C56E2D05",
    "form_completion_date": "2011-8-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2058
  },
  {
    "bcr_patient_uuid": "840FF11F-F991-4E1B-861B-98D236D573D3",
    "patient_ID": "TCGA.A5.A2K2",
    "bcr_drug_barcode": "TCGA-A5-A2K2-D17194",
    "bcr_drug_uuid": "BAD2B2D6-C341-44E0-A87C-0E8F4835BCEF",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 325,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1950
  },
  {
    "bcr_patient_uuid": "840FF11F-F991-4E1B-861B-98D236D573D3",
    "patient_ID": "TCGA.A5.A2K2",
    "bcr_drug_barcode": "TCGA-A5-A2K2-D17193",
    "bcr_drug_uuid": "C1DAC380-74A5-4888-8621-F4F181B86ECF",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "840FF11F-F991-4E1B-861B-98D236D573D3",
    "patient_ID": "TCGA.A5.A2K2",
    "bcr_drug_barcode": "TCGA-A5-A2K2-D17192",
    "bcr_drug_uuid": "302A50F6-6B97-4D89-B5ED-B2EAB07EDF69",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 165,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1655
  },
  {
    "bcr_patient_uuid": "C3096984-BD11-44A0-8EE0-47F07AD04D81",
    "patient_ID": "TCGA.A5.A2K3",
    "bcr_drug_barcode": "TCGA-A5-A2K3-D17200",
    "bcr_drug_uuid": "85B34B9C-7511-4D6B-A1D7-E86CA3D8AD29",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1908
  },
  {
    "bcr_patient_uuid": "C3096984-BD11-44A0-8EE0-47F07AD04D81",
    "patient_ID": "TCGA.A5.A2K3",
    "bcr_drug_barcode": "TCGA-A5-A2K3-D17201",
    "bcr_drug_uuid": "5CA3A84B-6811-4F7D-A57D-07C9D0C82B1C",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3978,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3978
  },
  {
    "bcr_patient_uuid": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640",
    "patient_ID": "TCGA.A5.A2K4",
    "bcr_drug_barcode": "TCGA-A5-A2K4-D17274",
    "bcr_drug_uuid": "F6F80664-E3EA-4E75-9631-EDB93ED7A4F2",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 821,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2430
  },
  {
    "bcr_patient_uuid": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640",
    "patient_ID": "TCGA.A5.A2K4",
    "bcr_drug_barcode": "TCGA-A5-A2K4-D17270",
    "bcr_drug_uuid": "2E187388-0443-4891-86F3-0AEDB3CC8495",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1431
  },
  {
    "bcr_patient_uuid": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640",
    "patient_ID": "TCGA.A5.A2K4",
    "bcr_drug_barcode": "TCGA-A5-A2K4-D17272",
    "bcr_drug_uuid": "2C20D72A-ADD3-480A-B0FB-CC2D719439F2",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 96
  },
  {
    "bcr_patient_uuid": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640",
    "patient_ID": "TCGA.A5.A2K4",
    "bcr_drug_barcode": "TCGA-A5-A2K4-D17273",
    "bcr_drug_uuid": "4C72394D-D669-4449-BF9C-85A70FFB588A",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640",
    "patient_ID": "TCGA.A5.A2K4",
    "bcr_drug_barcode": "TCGA-A5-A2K4-D17271",
    "bcr_drug_uuid": "FA98A5D6-0367-46E9-A147-3B8D42262AB1",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2245
  },
  {
    "bcr_patient_uuid": "F42868C0-FF59-438B-90A7-489AEA678DE9",
    "patient_ID": "TCGA.A5.A2K7",
    "bcr_drug_barcode": "TCGA-A5-A2K7-D19647",
    "bcr_drug_uuid": "7DC9E40C-0E1A-4B30-8BA3-E84C94631C0D",
    "form_completion_date": "2011-12-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 290
  },
  {
    "bcr_patient_uuid": "F42868C0-FF59-438B-90A7-489AEA678DE9",
    "patient_ID": "TCGA.A5.A2K7",
    "bcr_drug_barcode": "TCGA-A5-A2K7-D19648",
    "bcr_drug_uuid": "5E0EE4C2-7098-46B6-A148-A44817928C42",
    "form_completion_date": "2011-12-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 705
  },
  {
    "bcr_patient_uuid": "2A2BC155-CA7C-48B2-BB77-CCFD6313710A",
    "patient_ID": "TCGA.A5.A3LO",
    "bcr_drug_barcode": "TCGA-A5-A3LO-D29475",
    "bcr_drug_uuid": "032937DD-C5BE-466C-AB96-A58C1386D6A6",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "2A2BC155-CA7C-48B2-BB77-CCFD6313710A",
    "patient_ID": "TCGA.A5.A3LO",
    "bcr_drug_barcode": "TCGA-A5-A3LO-D29476",
    "bcr_drug_uuid": "F8BF146B-4B48-41DA-8D16-FD5F38CC0407",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2106
  },
  {
    "bcr_patient_uuid": "9BECF65D-01F2-4E84-A256-106002E22526",
    "patient_ID": "TCGA.A5.A3LP",
    "bcr_drug_barcode": "TCGA-A5-A3LP-D32261",
    "bcr_drug_uuid": "7628FE0F-F9AC-4382-B6F0-32D4DDA643CC",
    "form_completion_date": "2012-6-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DED408EE-053A-43ED-9BCF-1D15CD203051",
    "patient_ID": "TCGA.A5.A7WK",
    "bcr_drug_barcode": "TCGA-A5-A7WK-D54553",
    "bcr_drug_uuid": "DA131098-AD4C-4A8B-8DEE-1A8ECFDFE051",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DED408EE-053A-43ED-9BCF-1D15CD203051",
    "patient_ID": "TCGA.A5.A7WK",
    "bcr_drug_barcode": "TCGA-A5-A7WK-D63887",
    "bcr_drug_uuid": "F3EC705A-ACFA-4653-852A-BEA24B063880",
    "form_completion_date": "2014-8-20",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 357,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DED408EE-053A-43ED-9BCF-1D15CD203051",
    "patient_ID": "TCGA.A5.A7WK",
    "bcr_drug_barcode": "TCGA-A5-A7WK-D63888",
    "bcr_drug_uuid": "32E33543-0B54-4BB4-B9A8-7F8EB02ABF8C",
    "form_completion_date": "2014-8-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 506,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A67ED86-156F-4B45-B460-000FE33DA26B",
    "patient_ID": "TCGA.A5.AB3J",
    "bcr_drug_barcode": "TCGA-A5-AB3J-D64509",
    "bcr_drug_uuid": "0E4BDCD1-F711-434F-A96E-DAFFFD4F0AEA",
    "form_completion_date": "2014-9-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A67ED86-156F-4B45-B460-000FE33DA26B",
    "patient_ID": "TCGA.A5.AB3J",
    "bcr_drug_barcode": "TCGA-A5-AB3J-D64510",
    "bcr_drug_uuid": "B947E618-F799-4297-A396-8D9B78606682",
    "form_completion_date": "2014-9-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d39df936-4bc6-404d-9e1d-f6416cc5a34c",
    "patient_ID": "TCGA.AJ.A23M",
    "bcr_drug_barcode": "TCGA-AJ-A23M-D56160",
    "bcr_drug_uuid": "35730238-4EC2-42B2-95A0-8EA45CDB68A3",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D39E9A2-1073-4DB2-B02E-DB05D59563A7",
    "patient_ID": "TCGA.AJ.A23N",
    "bcr_drug_barcode": "TCGA-AJ-A23N-D47002",
    "bcr_drug_uuid": "6E45B1C4-453B-4EFB-82EB-0E2454D117C7",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D39E9A2-1073-4DB2-B02E-DB05D59563A7",
    "patient_ID": "TCGA.AJ.A23N",
    "bcr_drug_barcode": "TCGA-AJ-A23N-D47003",
    "bcr_drug_uuid": "D2E9275F-A4A8-4BA9-AD1D-93639EA4CCD8",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DE5ABE44-6D9D-4797-A57A-5ADFD71383F0",
    "patient_ID": "TCGA.AJ.A2QK",
    "bcr_drug_barcode": "TCGA-AJ-A2QK-D43982",
    "bcr_drug_uuid": "25884AC6-4CC0-4F58-9C20-BF68291A9054",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 643,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DE5ABE44-6D9D-4797-A57A-5ADFD71383F0",
    "patient_ID": "TCGA.AJ.A2QK",
    "bcr_drug_barcode": "TCGA-AJ-A2QK-D43984",
    "bcr_drug_uuid": "4EFEA08C-7285-4FA4-B0EF-55390C0C4862",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 653,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9002FC6C-26DE-4B8F-8985-A4814CD3DAF7",
    "patient_ID": "TCGA.AJ.A2QL",
    "bcr_drug_barcode": "TCGA-AJ-A2QL-D43203",
    "bcr_drug_uuid": "4F3B7D7F-44F2-4F6D-BCE8-BEFCEF897D2C",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9002FC6C-26DE-4B8F-8985-A4814CD3DAF7",
    "patient_ID": "TCGA.AJ.A2QL",
    "bcr_drug_barcode": "TCGA-AJ-A2QL-D43204",
    "bcr_drug_uuid": "E275FAC3-0AC4-4928-8021-B420F563DDE0",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9002FC6C-26DE-4B8F-8985-A4814CD3DAF7",
    "patient_ID": "TCGA.AJ.A2QL",
    "bcr_drug_barcode": "TCGA-AJ-A2QL-D43205",
    "bcr_drug_uuid": "B4080D73-4B0F-4F3C-99D6-CFE826761AAF",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9F4A2C1-AC6D-48C6-95FE-FFBC2FA08268",
    "patient_ID": "TCGA.AJ.A2QM",
    "bcr_drug_barcode": "TCGA-AJ-A2QM-D60108",
    "bcr_drug_uuid": "B6C68A8E-18AE-4391-AC33-E65312537A5C",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9F4A2C1-AC6D-48C6-95FE-FFBC2FA08268",
    "patient_ID": "TCGA.AJ.A2QM",
    "bcr_drug_barcode": "TCGA-AJ-A2QM-D60109",
    "bcr_drug_uuid": "FB5BCEB7-9935-4037-B737-E80CEF6F34D8",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AB68CD1B-5075-4B30-A829-D6D0F95871CB",
    "patient_ID": "TCGA.AJ.A3BD",
    "bcr_drug_barcode": "TCGA-AJ-A3BD-D58986",
    "bcr_drug_uuid": "3FCB21A4-FD2A-4040-95B8-3B6397B3E4FB",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AB68CD1B-5075-4B30-A829-D6D0F95871CB",
    "patient_ID": "TCGA.AJ.A3BD",
    "bcr_drug_barcode": "TCGA-AJ-A3BD-D58987",
    "bcr_drug_uuid": "F722F671-C70C-4C1B-92C2-7BBF3C0AA1B4",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "40287CDC-19DD-4370-A6A0-F324960E1148",
    "patient_ID": "TCGA.AJ.A3BF",
    "bcr_drug_barcode": "TCGA-AJ-A3BF-D43707",
    "bcr_drug_uuid": "B70B0072-3E60-4B87-B5F1-59E70158E987",
    "form_completion_date": "2013-5-31",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 251,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "40287CDC-19DD-4370-A6A0-F324960E1148",
    "patient_ID": "TCGA.AJ.A3BF",
    "bcr_drug_barcode": "TCGA-AJ-A3BF-D43708",
    "bcr_drug_uuid": "9EAFBEF3-C687-4E65-AFB6-2895D2221593",
    "form_completion_date": "2013-5-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 251,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77ED36AD-222F-4693-8668-0ECF9073D6E8",
    "patient_ID": "TCGA.AJ.A3BG",
    "bcr_drug_barcode": "TCGA-AJ-A3BG-D43758",
    "bcr_drug_uuid": "0F5FBEEC-3739-487C-9183-F35693BE775E",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77ED36AD-222F-4693-8668-0ECF9073D6E8",
    "patient_ID": "TCGA.AJ.A3BG",
    "bcr_drug_barcode": "TCGA-AJ-A3BG-D43760",
    "bcr_drug_uuid": "D0F37232-EE3C-4D29-9356-5F2DD29CC330",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77ED36AD-222F-4693-8668-0ECF9073D6E8",
    "patient_ID": "TCGA.AJ.A3BG",
    "bcr_drug_barcode": "TCGA-AJ-A3BG-D43761",
    "bcr_drug_uuid": "F2FDEBDF-282C-4493-8453-1A68F22F1C22",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 550,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77ED36AD-222F-4693-8668-0ECF9073D6E8",
    "patient_ID": "TCGA.AJ.A3BG",
    "bcr_drug_barcode": "TCGA-AJ-A3BG-D43762",
    "bcr_drug_uuid": "2A1C156B-815E-4D0C-BEEA-16FC5A8C3F9E",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 550,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "525FB4FC-2167-4506-B4FA-FB896BF64CD0",
    "patient_ID": "TCGA.AJ.A3BI",
    "bcr_drug_barcode": "TCGA-AJ-A3BI-D43703",
    "bcr_drug_uuid": "7BB8ECE4-8DE4-45BF-BDE8-5BD37D379F4D",
    "form_completion_date": "2013-5-31",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "525FB4FC-2167-4506-B4FA-FB896BF64CD0",
    "patient_ID": "TCGA.AJ.A3BI",
    "bcr_drug_barcode": "TCGA-AJ-A3BI-D43704",
    "bcr_drug_uuid": "168E2397-24D2-4A65-A6CD-B29A2C360180",
    "form_completion_date": "2013-5-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "14DB56EF-EC5E-4775-A229-5D83E58E027C",
    "patient_ID": "TCGA.AJ.A3EK",
    "bcr_drug_barcode": "TCGA-AJ-A3EK-D45628",
    "bcr_drug_uuid": "19CF2D0F-F0F2-4022-A95F-7ECBBA988851",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "14DB56EF-EC5E-4775-A229-5D83E58E027C",
    "patient_ID": "TCGA.AJ.A3EK",
    "bcr_drug_barcode": "TCGA-AJ-A3EK-D45629",
    "bcr_drug_uuid": "739D84CA-E206-428C-A852-CA1955C1F8BA",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E5D64754-15E8-494E-B7F7-25CF2819FE4C",
    "patient_ID": "TCGA.AJ.A3I9",
    "bcr_drug_barcode": "TCGA-AJ-A3I9-D66210",
    "bcr_drug_uuid": "FEB5FEE5-D836-45C0-8E36-AB467D7CCC17",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 456,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E5D64754-15E8-494E-B7F7-25CF2819FE4C",
    "patient_ID": "TCGA.AJ.A3I9",
    "bcr_drug_barcode": "TCGA-AJ-A3I9-D66211",
    "bcr_drug_uuid": "CC7E7973-9223-4A94-9844-A5D6D2FB49CA",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 456,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9FCBEF9E-2CCA-4033-B574-DAAB2A42198B",
    "patient_ID": "TCGA.AJ.A3NF",
    "bcr_drug_barcode": "TCGA-AJ-A3NF-D58991",
    "bcr_drug_uuid": "AFBEC5F6-6F1D-4F21-A2B6-329845104DE5",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7186180A-688A-4FCC-9A67-166EFF032E4B",
    "patient_ID": "TCGA.AJ.A3NH",
    "bcr_drug_barcode": "TCGA-AJ-A3NH-D46996",
    "bcr_drug_uuid": "032779E0-E851-4BE4-820B-C3A3DA4A174A",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7186180A-688A-4FCC-9A67-166EFF032E4B",
    "patient_ID": "TCGA.AJ.A3NH",
    "bcr_drug_barcode": "TCGA-AJ-A3NH-D46998",
    "bcr_drug_uuid": "1489C5E5-DCF2-4B32-8E18-000BD5A2A6D1",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76F98002-E8DF-4DFA-926E-8BB2D5114966",
    "patient_ID": "TCGA.AJ.A3OJ",
    "bcr_drug_barcode": "TCGA-AJ-A3OJ-D47052",
    "bcr_drug_uuid": "8001C500-87B1-4669-B411-188C137EC1A4",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 230,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76F98002-E8DF-4DFA-926E-8BB2D5114966",
    "patient_ID": "TCGA.AJ.A3OJ",
    "bcr_drug_barcode": "TCGA-AJ-A3OJ-D47053",
    "bcr_drug_uuid": "771E84E0-20EC-4A93-A3FC-2A7C2C6EA290",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 230,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12DF24C6-1229-4777-AD90-7DD66259B65F",
    "patient_ID": "TCGA.AJ.A3OK",
    "bcr_drug_barcode": "TCGA-AJ-A3OK-D45619",
    "bcr_drug_uuid": "B89731B9-8B66-4B3E-BCA0-5B73E019445A",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12DF24C6-1229-4777-AD90-7DD66259B65F",
    "patient_ID": "TCGA.AJ.A3OK",
    "bcr_drug_barcode": "TCGA-AJ-A3OK-D45620",
    "bcr_drug_uuid": "E39263BA-D6DB-4346-A475-A521DB6AB5BE",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12DF24C6-1229-4777-AD90-7DD66259B65F",
    "patient_ID": "TCGA.AJ.A3OK",
    "bcr_drug_barcode": "TCGA-AJ-A3OK-D45622",
    "bcr_drug_uuid": "DDF9A56B-8EF8-4109-8F6E-189529E11EDA",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7F91A0C5-D639-48EA-B3F7-B6F385E047ED",
    "patient_ID": "TCGA.AJ.A3OL",
    "bcr_drug_barcode": "TCGA-AJ-A3OL-D47008",
    "bcr_drug_uuid": "8888077B-E0BA-4F97-981B-D8BF33E45C57",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7F91A0C5-D639-48EA-B3F7-B6F385E047ED",
    "patient_ID": "TCGA.AJ.A3OL",
    "bcr_drug_barcode": "TCGA-AJ-A3OL-D47009",
    "bcr_drug_uuid": "F43F3E37-E6BD-46CB-B2F4-39211DF04578",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69FC74BC-E961-40E2-9169-D7B51658EB10",
    "patient_ID": "TCGA.AJ.A3QS",
    "bcr_drug_barcode": "TCGA-AJ-A3QS-D47015",
    "bcr_drug_uuid": "E8F22E51-4803-4AEB-BED5-17610F99AADB",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69FC74BC-E961-40E2-9169-D7B51658EB10",
    "patient_ID": "TCGA.AJ.A3QS",
    "bcr_drug_barcode": "TCGA-AJ-A3QS-D47016",
    "bcr_drug_uuid": "0A2D5771-5CE4-4EBE-8714-51908E04CBDA",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69FC74BC-E961-40E2-9169-D7B51658EB10",
    "patient_ID": "TCGA.AJ.A3QS",
    "bcr_drug_barcode": "TCGA-AJ-A3QS-D47017",
    "bcr_drug_uuid": "B866EAB5-4F40-40CB-9AA6-18C34C26DC62",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FAE3DBD7-1C4E-45C0-8187-C09892279565",
    "patient_ID": "TCGA.AJ.A4ZG",
    "bcr_drug_barcode": "TCGA-AJ-A4ZG-D58974",
    "bcr_drug_uuid": "3BAD017D-41EB-414E-98AD-1CF045E4F53E",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FAE3DBD7-1C4E-45C0-8187-C09892279565",
    "patient_ID": "TCGA.AJ.A4ZG",
    "bcr_drug_barcode": "TCGA-AJ-A4ZG-D58975",
    "bcr_drug_uuid": "C08C838A-5189-454E-87D7-9D5D6E5587DD",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FAE3DBD7-1C4E-45C0-8187-C09892279565",
    "patient_ID": "TCGA.AJ.A4ZG",
    "bcr_drug_barcode": "TCGA-AJ-A4ZG-D58976",
    "bcr_drug_uuid": "A7BEBB18-3531-4DF0-A454-0EB17682B7F9",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bd4284a7-260d-48b3-9b48-a1c578c30d27",
    "patient_ID": "TCGA.AP.A052",
    "bcr_drug_barcode": "TCGA-AP-A052-D3402",
    "bcr_drug_uuid": "40f920f3-7448-473a-8d58-69a1f689e3c9",
    "form_completion_date": "2010-8-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 406,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "bd4284a7-260d-48b3-9b48-a1c578c30d27",
    "patient_ID": "TCGA.AP.A052",
    "bcr_drug_barcode": "TCGA-AP-A052-D3400",
    "bcr_drug_uuid": "6ab9f48b-ff95-4e28-b112-c2c7dfed015e",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2550
  },
  {
    "bcr_patient_uuid": "bd4284a7-260d-48b3-9b48-a1c578c30d27",
    "patient_ID": "TCGA.AP.A052",
    "bcr_drug_barcode": "TCGA-AP-A052-D3403",
    "bcr_drug_uuid": "1db600a8-0509-472b-a6ab-9db84b95765b",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 406,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 469,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 550,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7700
  },
  {
    "bcr_patient_uuid": "bd4284a7-260d-48b3-9b48-a1c578c30d27",
    "patient_ID": "TCGA.AP.A052",
    "bcr_drug_barcode": "TCGA-AP-A052-D3396",
    "bcr_drug_uuid": "c8f72a13-f527-4b75-bbd3-41df2188ec10",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "d77e4dbc-b239-4742-8cb7-efd427010d13",
    "patient_ID": "TCGA.AP.A054",
    "bcr_drug_barcode": "TCGA-AP-A054-D3411",
    "bcr_drug_uuid": "eee7e85b-987a-42e9-bd83-21800963ab15",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "d77e4dbc-b239-4742-8cb7-efd427010d13",
    "patient_ID": "TCGA.AP.A054",
    "bcr_drug_barcode": "TCGA-AP-A054-D3413",
    "bcr_drug_uuid": "3b17d704-bdc4-42ae-af5c-4a0c584909ae",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2868
  },
  {
    "bcr_patient_uuid": "c350b53b-3c27-4b9e-8b57-d7b6a1205a1f",
    "patient_ID": "TCGA.AP.A05A",
    "bcr_drug_barcode": "TCGA-AP-A05A-D3429",
    "bcr_drug_uuid": "8f102c10-660c-4ae2-b4b1-7b42079dc933",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f7e06a10-74ca-4f52-a944-b3f22c016998",
    "patient_ID": "TCGA.AP.A05D",
    "bcr_drug_barcode": "TCGA-AP-A05D-D8497",
    "bcr_drug_uuid": "1688C832-9BC6-4E06-BB28-23A0113F8E00",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 395
  },
  {
    "bcr_patient_uuid": "f7e06a10-74ca-4f52-a944-b3f22c016998",
    "patient_ID": "TCGA.AP.A05D",
    "bcr_drug_barcode": "TCGA-AP-A05D-D8499",
    "bcr_drug_uuid": "1781CE9C-F5E2-4E43-A493-3ED07848847E",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1380
  },
  {
    "bcr_patient_uuid": "f7e06a10-74ca-4f52-a944-b3f22c016998",
    "patient_ID": "TCGA.AP.A05D",
    "bcr_drug_barcode": "TCGA-AP-A05D-D8498",
    "bcr_drug_uuid": "C38A0BEE-B876-4DC4-9CC1-7B64ABED1AAC",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2165
  },
  {
    "bcr_patient_uuid": "fe5f4822-37a3-4f9e-8d33-8b9f36bf6895",
    "patient_ID": "TCGA.AP.A05H",
    "bcr_drug_barcode": "TCGA-AP-A05H-D3481",
    "bcr_drug_uuid": "6554051b-6dd6-42f2-9204-e0135d6b0d80",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2340
  },
  {
    "bcr_patient_uuid": "fe5f4822-37a3-4f9e-8d33-8b9f36bf6895",
    "patient_ID": "TCGA.AP.A05H",
    "bcr_drug_barcode": "TCGA-AP-A05H-D3480",
    "bcr_drug_uuid": "d58e5f44-7f50-4ccc-b959-f10251e843c6",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "38f9fe64-de79-498c-b3ca-1c83af0ed72a",
    "patient_ID": "TCGA.AP.A05J",
    "bcr_drug_barcode": "TCGA-AP-A05J-D3491",
    "bcr_drug_uuid": "e924ff94-35dc-4c2a-89ee-0684fa0d0a46",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1944
  },
  {
    "bcr_patient_uuid": "38f9fe64-de79-498c-b3ca-1c83af0ed72a",
    "patient_ID": "TCGA.AP.A05J",
    "bcr_drug_barcode": "TCGA-AP-A05J-D3492",
    "bcr_drug_uuid": "234f4d38-1814-4f5a-a863-8dac10af827f",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2562
  },
  {
    "bcr_patient_uuid": "49431740-7ed1-4c67-8d66-730629825895",
    "patient_ID": "TCGA.AP.A05O",
    "bcr_drug_barcode": "TCGA-AP-A05O-D8515",
    "bcr_drug_uuid": "15029BEF-5825-4937-A6C1-A626C212C5DB",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1210
  },
  {
    "bcr_patient_uuid": "49431740-7ed1-4c67-8d66-730629825895",
    "patient_ID": "TCGA.AP.A05O",
    "bcr_drug_barcode": "TCGA-AP-A05O-D8519",
    "bcr_drug_uuid": "E3CF15C9-B06B-4206-867A-B22F09178955",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 620
  },
  {
    "bcr_patient_uuid": "7dce4215-01f6-43e9-9378-9e22c26c23a2",
    "patient_ID": "TCGA.AP.A0LH",
    "bcr_drug_barcode": "TCGA-AP-A0LH-D3954",
    "bcr_drug_uuid": "86ba0671-449d-4227-bde4-4f3149766e9d",
    "form_completion_date": "2010-8-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1932
  },
  {
    "bcr_patient_uuid": "7dce4215-01f6-43e9-9378-9e22c26c23a2",
    "patient_ID": "TCGA.AP.A0LH",
    "bcr_drug_barcode": "TCGA-AP-A0LH-D3956",
    "bcr_drug_uuid": "d55838a0-6c0a-4a7a-8c9c-e14d2b45859b",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "7dce4215-01f6-43e9-9378-9e22c26c23a2",
    "patient_ID": "TCGA.AP.A0LH",
    "bcr_drug_barcode": "TCGA-AP-A0LH-D3959",
    "bcr_drug_uuid": "6a414769-0417-46de-a374-32a6a0ba33ea",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 750,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 16560
  },
  {
    "bcr_patient_uuid": "7dce4215-01f6-43e9-9378-9e22c26c23a2",
    "patient_ID": "TCGA.AP.A0LH",
    "bcr_drug_barcode": "TCGA-AP-A0LH-D3957",
    "bcr_drug_uuid": "ab565418-658d-47b0-93b4-bfeb643e5319",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "IXABEPILONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 324,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 330
  },
  {
    "bcr_patient_uuid": "e1e8dc66-467c-48a5-be56-3db4f665b9f1",
    "patient_ID": "TCGA.AP.A0LI",
    "bcr_drug_barcode": "TCGA-AP-A0LI-D3970",
    "bcr_drug_uuid": "7b5bc501-0cbb-4242-8002-327283e9985d",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2016
  },
  {
    "bcr_patient_uuid": "e1e8dc66-467c-48a5-be56-3db4f665b9f1",
    "patient_ID": "TCGA.AP.A0LI",
    "bcr_drug_barcode": "TCGA-AP-A0LI-D3972",
    "bcr_drug_uuid": "68978557-66c6-47bc-866d-ee01ee077fed",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2382
  },
  {
    "bcr_patient_uuid": "d17668c4-5d66-4e16-8b70-b54616581aae",
    "patient_ID": "TCGA.AP.A0LL",
    "bcr_drug_barcode": "TCGA-AP-A0LL-D4011",
    "bcr_drug_uuid": "bff43ef5-4738-48be-ae83-b47bbc5ae094",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 829,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1133,
    "drug_cycles": 7,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 24640
  },
  {
    "bcr_patient_uuid": "d17668c4-5d66-4e16-8b70-b54616581aae",
    "patient_ID": "TCGA.AP.A0LL",
    "bcr_drug_barcode": "TCGA-AP-A0LL-D4009",
    "bcr_drug_uuid": "438a5990-94f3-46bb-bbb9-9e49a802ad78",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 829,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1133,
    "drug_cycles": 7,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "43e228ae-c890-444f-afbd-49385562e33a",
    "patient_ID": "TCGA.AP.A0LM",
    "bcr_drug_barcode": "TCGA-AP-A0LM-D8525",
    "bcr_drug_uuid": "60BC8D79-9AA9-49C8-AA66-74B69157CAD3",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "efae3940-d3cc-4988-bdb4-fa05d977aff5",
    "patient_ID": "TCGA.AP.A0LP",
    "bcr_drug_barcode": "TCGA-AP-A0LP-D4031",
    "bcr_drug_uuid": "ddc3dd92-e5c2-4dc7-b394-3ef8b811ed81",
    "form_completion_date": "2010-9-23",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 391,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 53440
  },
  {
    "bcr_patient_uuid": "a93c47a9-65b5-4785-af4f-a2078db4514e",
    "patient_ID": "TCGA.AP.A1DP",
    "bcr_drug_barcode": "TCGA-AP-A1DP-D13649",
    "bcr_drug_uuid": "0657F934-96C7-49EE-9523-6B4302A2D6B8",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 903,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 987,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2675
  },
  {
    "bcr_patient_uuid": "a93c47a9-65b5-4785-af4f-a2078db4514e",
    "patient_ID": "TCGA.AP.A1DP",
    "bcr_drug_barcode": "TCGA-AP-A1DP-D13650",
    "bcr_drug_uuid": "38988CFE-99F6-45EC-A32D-6B32C87377CC",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 903,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 987,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1340
  },
  {
    "bcr_patient_uuid": "ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0",
    "patient_ID": "TCGA.AP.A1DQ",
    "bcr_drug_barcode": "TCGA-AP-A1DQ-D13653",
    "bcr_drug_uuid": "F8281007-6733-4F30-B706-3581CE0AAAB5",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0",
    "patient_ID": "TCGA.AP.A1DQ",
    "bcr_drug_barcode": "TCGA-AP-A1DQ-D13654",
    "bcr_drug_uuid": "AC3560E4-DCE6-4D5F-A21F-C4C39CAE22B8",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 924,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0f064588-2d7e-439a-90a6-dfa17bb8af15",
    "patient_ID": "TCGA.AP.A1DR",
    "bcr_drug_barcode": "TCGA-AP-A1DR-D13633",
    "bcr_drug_uuid": "3F59D717-D5F2-491C-8B76-85DE038AEF01",
    "form_completion_date": "2011-7-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "0f064588-2d7e-439a-90a6-dfa17bb8af15",
    "patient_ID": "TCGA.AP.A1DR",
    "bcr_drug_barcode": "TCGA-AP-A1DR-D13629",
    "bcr_drug_uuid": "F28A5D76-6DB1-4279-B8D8-CE825F7D81FD",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "0f064588-2d7e-439a-90a6-dfa17bb8af15",
    "patient_ID": "TCGA.AP.A1DR",
    "bcr_drug_barcode": "TCGA-AP-A1DR-D13630",
    "bcr_drug_uuid": "219FB6EF-5308-4429-922A-03F4907EE267",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 496,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1984
  },
  {
    "bcr_patient_uuid": "84b96f93-6273-4101-a259-9602000ae491",
    "patient_ID": "TCGA.AP.A1E0",
    "bcr_drug_barcode": "TCGA-AP-A1E0-D13639",
    "bcr_drug_uuid": "B71376C6-4A68-4B3F-A066-9480DC9051C9",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "84b96f93-6273-4101-a259-9602000ae491",
    "patient_ID": "TCGA.AP.A1E0",
    "bcr_drug_barcode": "TCGA-AP-A1E0-D13638",
    "bcr_drug_uuid": "6FF7D138-6BB5-4B59-8924-8FEC1A366E2D",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "44ac7093-a733-4c55-a964-0ba9ec141d2d",
    "patient_ID": "TCGA.AP.A1E3",
    "bcr_drug_barcode": "TCGA-AP-A1E3-D14427",
    "bcr_drug_uuid": "E2E0DB86-9AA0-42BA-AD91-BAC168CC3F3C",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "44ac7093-a733-4c55-a964-0ba9ec141d2d",
    "patient_ID": "TCGA.AP.A1E3",
    "bcr_drug_barcode": "TCGA-AP-A1E3-D14425",
    "bcr_drug_uuid": "E5B6F694-9767-4495-87FA-EDD47105BE19",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 45,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "0b2eb188-dd23-4dbf-91bb-02e3c81a69bc",
    "patient_ID": "TCGA.AP.A1E4",
    "bcr_drug_barcode": "TCGA-AP-A1E4-D13643",
    "bcr_drug_uuid": "CCFDF7A5-C9D9-4559-9E85-E3B3354993A8",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 204,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 309,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2860
  },
  {
    "bcr_patient_uuid": "0b2eb188-dd23-4dbf-91bb-02e3c81a69bc",
    "patient_ID": "TCGA.AP.A1E4",
    "bcr_drug_barcode": "TCGA-AP-A1E4-D13644",
    "bcr_drug_uuid": "8B742152-FB82-4322-827B-91C8D8B9877C",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 204,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 309,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "0b2eb188-dd23-4dbf-91bb-02e3c81a69bc",
    "patient_ID": "TCGA.AP.A1E4",
    "bcr_drug_barcode": "TCGA-AP-A1E4-D16683",
    "bcr_drug_uuid": "F308AF29-4335-4BB5-9E88-B86DF3E5094B",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 344,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821",
    "patient_ID": "TCGA.AP.A3K1",
    "bcr_drug_barcode": "TCGA-AP-A3K1-D38426",
    "bcr_drug_uuid": "E86FFFCA-37BD-485D-89ED-6C7C29996571",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821",
    "patient_ID": "TCGA.AP.A3K1",
    "bcr_drug_barcode": "TCGA-AP-A3K1-D38427",
    "bcr_drug_uuid": "131286E9-23BB-49BC-906B-7920CA6C1439",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821",
    "patient_ID": "TCGA.AP.A3K1",
    "bcr_drug_barcode": "TCGA-AP-A3K1-D38428",
    "bcr_drug_uuid": "8F5EF5CB-7E76-4E8D-ADE9-D17122AE1299",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821",
    "patient_ID": "TCGA.AP.A3K1",
    "bcr_drug_barcode": "TCGA-AP-A3K1-D38429",
    "bcr_drug_uuid": "57F15663-9B00-450F-A66F-657538903AF8",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821",
    "patient_ID": "TCGA.AP.A3K1",
    "bcr_drug_barcode": "TCGA-AP-A3K1-D38430",
    "bcr_drug_uuid": "BE8B156A-C9F4-4059-932A-76105B1F8BEE",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A633D316-59A4-45AE-8BF8-135CFBD27656",
    "patient_ID": "TCGA.AP.A5FX",
    "bcr_drug_barcode": "TCGA-AP-A5FX-D43566",
    "bcr_drug_uuid": "9FF793C4-98A5-48F8-95C6-43756F12F395",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A633D316-59A4-45AE-8BF8-135CFBD27656",
    "patient_ID": "TCGA.AP.A5FX",
    "bcr_drug_barcode": "TCGA-AP-A5FX-D43567",
    "bcr_drug_uuid": "617CCEA3-B4DB-4ED7-B47A-091839244529",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3a4a6aff-4720-41fc-a114-85f38610ebb1",
    "patient_ID": "TCGA.AX.A05S",
    "bcr_drug_barcode": "TCGA-AX-A05S-D12766",
    "bcr_drug_uuid": "db45013e-6d45-4748-b07f-36125c804f98",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN & PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D12784",
    "bcr_drug_uuid": "e3d8e471-f163-40e7-9b66-972e5bbe4fa0",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 2,
    "regimen_number": 2,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PT. REQUEST OF LESS HARSH THERAPY"
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D5562",
    "bcr_drug_uuid": "c2b7c9e7-5b59-4d55-af34-da12e01c1a0f",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D72579",
    "bcr_drug_uuid": "AED1C2C2-7D5B-4C3C-8595-73D0FFE4A7B4",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D72580",
    "bcr_drug_uuid": "2866F77C-4006-4F98-97CF-E73DA2860FF1",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D72581",
    "bcr_drug_uuid": "8354DEBB-76FE-4249-9981-43B6A9DA6DBA",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "bf632368-8ce7-4b4b-8842-d1b1801e62ef",
    "patient_ID": "TCGA.AX.A05Z",
    "bcr_drug_barcode": "TCGA-AX-A05Z-D72582",
    "bcr_drug_uuid": "0953162E-D9B2-4E5F-A3A0-362A40DC7D50",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 152,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "d1b615f4-50c9-497b-8a69-8de78aa17e09",
    "patient_ID": "TCGA.AX.A060",
    "bcr_drug_barcode": "TCGA-AX-A060-D12750",
    "bcr_drug_uuid": "1108b4c7-d534-4ad3-b751-fbcb294365cf",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "905291b0-f077-48f7-9c14-5cfa9d8a3e6e",
    "patient_ID": "TCGA.AX.A06D",
    "bcr_drug_barcode": "TCGA-AX-A06D-D9719",
    "bcr_drug_uuid": "B3FB8411-8425-4300-ADD3-FBA4F6CC6747",
    "form_completion_date": "2011-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN & PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "905291b0-f077-48f7-9c14-5cfa9d8a3e6e",
    "patient_ID": "TCGA.AX.A06D",
    "bcr_drug_barcode": "TCGA-AX-A06D-D9720",
    "bcr_drug_uuid": "4229E0CA-0DFF-4D42-A55A-308C2900AD6F",
    "form_completion_date": "2011-5-13",
    "pharmaceutical_therapy_drug_name": "VEGF-TRAP",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 327
  },
  {
    "bcr_patient_uuid": "f17e446a-c145-45be-8335-a856acb0b9b8",
    "patient_ID": "TCGA.AX.A06F",
    "bcr_drug_barcode": "TCGA-AX-A06F-D12757",
    "bcr_drug_uuid": "36b831cc-6603-487d-a60e-5910f9bfb28d",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3755
  },
  {
    "bcr_patient_uuid": "f17e446a-c145-45be-8335-a856acb0b9b8",
    "patient_ID": "TCGA.AX.A06F",
    "bcr_drug_barcode": "TCGA-AX-A06F-D12989",
    "bcr_drug_uuid": "db07fc03-5db7-4f7c-b852-3c7dead35e6d",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1630
  },
  {
    "bcr_patient_uuid": "e5d74e47-b63f-410a-8b7a-c9aacc9aa337",
    "patient_ID": "TCGA.AX.A06H",
    "bcr_drug_barcode": "TCGA-AX-A06H-D9724",
    "bcr_drug_uuid": "A01AE370-01D3-4201-8F91-6291638862AA",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2263
  },
  {
    "bcr_patient_uuid": "e5d74e47-b63f-410a-8b7a-c9aacc9aa337",
    "patient_ID": "TCGA.AX.A06H",
    "bcr_drug_barcode": "TCGA-AX-A06H-D9723",
    "bcr_drug_uuid": "3C122F84-3819-4011-9904-6FBB7085D3D3",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "drug_cycles": 7,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2917
  },
  {
    "bcr_patient_uuid": "b6819b52-6f01-4011-9bd3-a1a00397e0c9",
    "patient_ID": "TCGA.AX.A06J",
    "bcr_drug_barcode": "TCGA-AX-A06J-D12764",
    "bcr_drug_uuid": "9e8a69c1-c059-4825-852b-bb1425ebe778",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN & PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D9733",
    "bcr_drug_uuid": "1804ED55-A680-4042-97A8-7AEAA0781EDF",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D9735",
    "bcr_drug_uuid": "D6F34351-5EF7-42FE-8572-61F04F907231",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D12201",
    "bcr_drug_uuid": "2609D4F8-E7FE-442F-BFF8-9288C9D0D7DF",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "TIVOZANIB",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1065,
    "pharma_type_other": "INVESTIGATIONAL NEW DRUG",
    "regimen_number": 5,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D9737",
    "bcr_drug_uuid": "DE843F83-2D05-474D-894B-730CC46BEEC9",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "BRIVANIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY|TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 513,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 3,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D9738",
    "bcr_drug_uuid": "938CE73E-C09C-4433-B0CF-876A06DAC555",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 583,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2e5cf721-90b1-4470-b430-f055a1297c7f",
    "patient_ID": "TCGA.AX.A0IS",
    "bcr_drug_barcode": "TCGA-AX-A0IS-D72575",
    "bcr_drug_uuid": "685B7ECA-2493-4419-B59D-B970C435958D",
    "form_completion_date": "2015-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "clinical_trial_drug_classification": "ADJUVANT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "7e64ea6c-a3db-48eb-91be-131361510a92",
    "patient_ID": "TCGA.AX.A0IU",
    "bcr_drug_barcode": "TCGA-AX-A0IU-D12239",
    "bcr_drug_uuid": "9E174F7B-C2D1-4CCB-A9DB-C0DEBBF4E4D1",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7e64ea6c-a3db-48eb-91be-131361510a92",
    "patient_ID": "TCGA.AX.A0IU",
    "bcr_drug_barcode": "TCGA-AX-A0IU-D72583",
    "bcr_drug_uuid": "02B72A7C-1C19-4157-AEB8-46C743AE9DDA",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "db21fccf-40cb-4235-a34d-336a03b8c8f4",
    "patient_ID": "TCGA.AX.A0IW",
    "bcr_drug_barcode": "TCGA-AX-A0IW-D12240",
    "bcr_drug_uuid": "506B4C7E-1E72-4FAD-AC06-63DC04CA606B",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN & PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "caebdce0-f954-471a-ac63-5daaa2e76d97",
    "patient_ID": "TCGA.AX.A1C5",
    "bcr_drug_barcode": "TCGA-AX-A1C5-D10398",
    "bcr_drug_uuid": "495F644C-3B05-487A-8800-7FEFA6A369A2",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "caebdce0-f954-471a-ac63-5daaa2e76d97",
    "patient_ID": "TCGA.AX.A1C5",
    "bcr_drug_barcode": "TCGA-AX-A1C5-D72584",
    "bcr_drug_uuid": "FF91CD4E-D3CA-4AAA-8FB1-517754BDB046",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "755d7ab7-4563-408a-9135-f852048af975",
    "patient_ID": "TCGA.AX.A1C7",
    "bcr_drug_barcode": "TCGA-AX-A1C7-D10358",
    "bcr_drug_uuid": "6AD2DACC-DCBA-4C0E-B0EA-BA18D224D804",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "755d7ab7-4563-408a-9135-f852048af975",
    "patient_ID": "TCGA.AX.A1C7",
    "bcr_drug_barcode": "TCGA-AX-A1C7-D12488",
    "bcr_drug_uuid": "7E25AA3C-5876-4354-9F92-66DF3C981FE0",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 434,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "755d7ab7-4563-408a-9135-f852048af975",
    "patient_ID": "TCGA.AX.A1C7",
    "bcr_drug_barcode": "TCGA-AX-A1C7-D72585",
    "bcr_drug_uuid": "6DE552A0-05F3-4735-B454-C6C6CA8ACD54",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "bad34c92-1e64-4187-a0b4-061105fd13ba",
    "patient_ID": "TCGA.AX.A1C8",
    "bcr_drug_barcode": "TCGA-AX-A1C8-D10363",
    "bcr_drug_uuid": "7693621F-028E-40DE-8637-FF396CA1194E",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bad34c92-1e64-4187-a0b4-061105fd13ba",
    "patient_ID": "TCGA.AX.A1C8",
    "bcr_drug_barcode": "TCGA-AX-A1C8-D72586",
    "bcr_drug_uuid": "1CE11EA3-2A1B-4ED4-B3E7-5B356A100189",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee",
    "patient_ID": "TCGA.AX.A1CA",
    "bcr_drug_barcode": "TCGA-AX-A1CA-D10393",
    "bcr_drug_uuid": "74563F71-49F3-4A38-B001-6ECF8D44D778",
    "form_completion_date": "2011-3-11",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee",
    "patient_ID": "TCGA.AX.A1CA",
    "bcr_drug_barcode": "TCGA-AX-A1CA-D10392",
    "bcr_drug_uuid": "29F90ACB-04D0-472E-9076-587F9C90F663",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee",
    "patient_ID": "TCGA.AX.A1CA",
    "bcr_drug_barcode": "TCGA-AX-A1CA-D72587",
    "bcr_drug_uuid": "55B381E9-BEF3-4042-8CFA-B033F65701C5",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee",
    "patient_ID": "TCGA.AX.A1CA",
    "bcr_drug_barcode": "TCGA-AX-A1CA-D72588",
    "bcr_drug_uuid": "BF635F5C-1583-4E04-83A5-51A02275DFE3",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "bc02493a-0296-4329-939a-bf91a4d0c16a",
    "patient_ID": "TCGA.AX.A1CC",
    "bcr_drug_barcode": "TCGA-AX-A1CC-D10389",
    "bcr_drug_uuid": "AD3D9A7E-5595-4BB3-A061-76240CB78F37",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc02493a-0296-4329-939a-bf91a4d0c16a",
    "patient_ID": "TCGA.AX.A1CC",
    "bcr_drug_barcode": "TCGA-AX-A1CC-D72589",
    "bcr_drug_uuid": "727F5940-7257-4588-B4B5-E273821F1717",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4db38349-28d2-4af5-a12f-3d861937b0e0",
    "patient_ID": "TCGA.AX.A1CE",
    "bcr_drug_barcode": "TCGA-AX-A1CE-D10385",
    "bcr_drug_uuid": "B74A4A56-4697-4F6C-BF9E-917453123A7B",
    "form_completion_date": "2011-3-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4db38349-28d2-4af5-a12f-3d861937b0e0",
    "patient_ID": "TCGA.AX.A1CE",
    "bcr_drug_barcode": "TCGA-AX-A1CE-D10384",
    "bcr_drug_uuid": "2636C002-D0BC-4B88-8C38-BFAEF1DFB7F5",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20dcf91a-0529-4e96-99a2-362a41fbe4a4",
    "patient_ID": "TCGA.AX.A1CF",
    "bcr_drug_barcode": "TCGA-AX-A1CF-D10341",
    "bcr_drug_uuid": "6F9974DF-0FED-49AE-BD30-97588AFAFB44",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN & MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1037,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "20dcf91a-0529-4e96-99a2-362a41fbe4a4",
    "patient_ID": "TCGA.AX.A1CF",
    "bcr_drug_barcode": "TCGA-AX-A1CF-D10344",
    "bcr_drug_uuid": "8EAD2867-53E5-4C4D-B1D4-07B088759489",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1799,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "20dcf91a-0529-4e96-99a2-362a41fbe4a4",
    "patient_ID": "TCGA.AX.A1CF",
    "bcr_drug_barcode": "TCGA-AX-A1CF-D12374",
    "bcr_drug_uuid": "694F4296-D3D4-4D80-916E-D76659AAC723",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2052,
    "regimen_number": 3,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT"
  },
  {
    "bcr_patient_uuid": "45effb44-0b5f-4081-a202-d85969c72f2b",
    "patient_ID": "TCGA.AX.A1CK",
    "bcr_drug_barcode": "TCGA-AX-A1CK-D10306",
    "bcr_drug_uuid": "13B73BD6-A192-43A9-B501-78E1BF2623AE",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d70b3c6e-04da-4abc-a832-a461e4cfcc94",
    "patient_ID": "TCGA.AX.A1CN",
    "bcr_drug_barcode": "TCGA-AX-A1CN-D10302",
    "bcr_drug_uuid": "4A045393-A193-45B9-963C-798628FF22FB",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d70b3c6e-04da-4abc-a832-a461e4cfcc94",
    "patient_ID": "TCGA.AX.A1CN",
    "bcr_drug_barcode": "TCGA-AX-A1CN-D72592",
    "bcr_drug_uuid": "B84BCDEB-F1FB-4020-BD65-C93F880E83D2",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3abaa1b6-7513-40e0-b79c-b968e788e932",
    "patient_ID": "TCGA.AX.A1CR",
    "bcr_drug_barcode": "TCGA-AX-A1CR-D12542",
    "bcr_drug_uuid": "0B327E23-0AFF-4E19-A4B2-D223BDC3D384",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3abaa1b6-7513-40e0-b79c-b968e788e932",
    "patient_ID": "TCGA.AX.A1CR",
    "bcr_drug_barcode": "TCGA-AX-A1CR-D65237",
    "bcr_drug_uuid": "04B2EE98-A5C4-44DA-AC76-6EAD784FF4DB",
    "form_completion_date": "2014-9-19",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "days_to_drug_start": 376,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 463,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3abaa1b6-7513-40e0-b79c-b968e788e932",
    "patient_ID": "TCGA.AX.A1CR",
    "bcr_drug_barcode": "TCGA-AX-A1CR-D72590",
    "bcr_drug_uuid": "A77F89CD-5D1E-4971-9FD9-E30974DB766C",
    "form_completion_date": "2015-7-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "clinical_trial_drug_classification": "ADJUVENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C88E3901-F3EE-436A-BA80-143C8EAB7D69",
    "patient_ID": "TCGA.AX.A2H5",
    "bcr_drug_barcode": "TCGA-AX-A2H5-D31627",
    "bcr_drug_uuid": "0AFBEB24-6412-46F6-AEDC-86C5B467EA5B",
    "form_completion_date": "2012-5-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "C88E3901-F3EE-436A-BA80-143C8EAB7D69",
    "patient_ID": "TCGA.AX.A2H5",
    "bcr_drug_barcode": "TCGA-AX-A2H5-D31628",
    "bcr_drug_uuid": "C0052967-B2FB-43B6-A100-E42026C41CDE",
    "form_completion_date": "2012-5-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7",
    "patient_ID": "TCGA.AX.A2HC",
    "bcr_drug_barcode": "TCGA-AX-A2HC-D31747",
    "bcr_drug_uuid": "4379F374-9DD4-42B4-BC0C-062928C2E36C",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7",
    "patient_ID": "TCGA.AX.A2HC",
    "bcr_drug_barcode": "TCGA-AX-A2HC-D31749",
    "bcr_drug_uuid": "5227FAE7-1106-4F3C-9569-9C8B44F59613",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 974,
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "7A077812-F6EE-4820-A084-1A52C7EF062C",
    "patient_ID": "TCGA.AX.A2HF",
    "bcr_drug_barcode": "TCGA-AX-A2HF-D31636",
    "bcr_drug_uuid": "3DF9A8C9-C911-41A9-8A5B-D4CE9B23EECC",
    "form_completion_date": "2012-5-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "7A077812-F6EE-4820-A084-1A52C7EF062C",
    "patient_ID": "TCGA.AX.A2HF",
    "bcr_drug_barcode": "TCGA-AX-A2HF-D31638",
    "bcr_drug_uuid": "B9AC5C39-4A2A-4B0F-97E0-E5E78A9C6D83",
    "form_completion_date": "2012-5-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "8A235D4D-5EE1-4D6B-839E-E71CADCD8C39",
    "patient_ID": "TCGA.AX.A2IO",
    "bcr_drug_barcode": "TCGA-AX-A2IO-D58278",
    "bcr_drug_uuid": "D6ADB87E-DFE5-4059-8FD0-C350D8558938",
    "form_completion_date": "2014-4-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN, TAXOL",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F45A2E9-1CA5-438C-B06F-1CD8EB845465",
    "patient_ID": "TCGA.AX.A3FX",
    "bcr_drug_barcode": "TCGA-AX-A3FX-D58284",
    "bcr_drug_uuid": "B02ADA31-C816-4833-8048-3B68E84B00C6",
    "form_completion_date": "2014-4-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN/PACLITAXEL/BEVACIZUMAB",
    "days_to_drug_start": 939,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F45A2E9-1CA5-438C-B06F-1CD8EB845465",
    "patient_ID": "TCGA.AX.A3FX",
    "bcr_drug_barcode": "TCGA-AX-A3FX-D58285",
    "bcr_drug_uuid": "EA51A083-1FBD-4AB6-B35C-3F176DB5DD98",
    "form_completion_date": "2014-4-3",
    "pharmaceutical_therapy_drug_name": "DOXIL & CARBOPLATIN",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1336,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F7527B5E-5330-49EA-82CE-F6F2CDCCBADC",
    "patient_ID": "TCGA.AX.A3G9",
    "bcr_drug_barcode": "TCGA-AX-A3G9-D21263",
    "bcr_drug_uuid": "BFF8CB90-1B48-49DB-83B7-62E283B99B62",
    "form_completion_date": "2012-2-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN AND PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "AA3AD7C0-37CF-4337-945E-CEFEEE801BBB",
    "patient_ID": "TCGA.AX.A3GB",
    "bcr_drug_barcode": "TCGA-AX-A3GB-D21267",
    "bcr_drug_uuid": "3B825A9D-4B06-44FF-9000-C02FA665379E",
    "form_completion_date": "2012-2-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN AND PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b60f22ac-a659-4f33-b01d-820e86a9a5c9",
    "patient_ID": "TCGA.B5.A0JN",
    "bcr_drug_barcode": "TCGA-B5-A0JN-D9970",
    "bcr_drug_uuid": "677735f5-36eb-4b4a-9e75-b43ac1ec0b33",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b60f22ac-a659-4f33-b01d-820e86a9a5c9",
    "patient_ID": "TCGA.B5.A0JN",
    "bcr_drug_barcode": "TCGA-B5-A0JN-D9968",
    "bcr_drug_uuid": "ba6f77a1-fc03-4924-9edc-5198afbb6a77",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 275,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d5f2bae1-7cd1-49bf-ae41-12d2aa44408e",
    "patient_ID": "TCGA.B5.A0JT",
    "bcr_drug_barcode": "TCGA-B5-A0JT-D10042",
    "bcr_drug_uuid": "c1d3dd4e-523f-4056-b92e-14a764eb235e",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61935424-44d0-4211-81c1-c925e436eac5",
    "patient_ID": "TCGA.B5.A0JY",
    "bcr_drug_barcode": "TCGA-B5-A0JY-D5690",
    "bcr_drug_uuid": "606f7032-1135-4536-b460-db2e505ae1a4",
    "form_completion_date": "2011-1-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61935424-44d0-4211-81c1-c925e436eac5",
    "patient_ID": "TCGA.B5.A0JY",
    "bcr_drug_barcode": "TCGA-B5-A0JY-D5689",
    "bcr_drug_uuid": "6d97c160-0db3-4d36-b996-8c00735df3cf",
    "form_completion_date": "2011-1-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61935424-44d0-4211-81c1-c925e436eac5",
    "patient_ID": "TCGA.B5.A0JY",
    "bcr_drug_barcode": "TCGA-B5-A0JY-D5688",
    "bcr_drug_uuid": "7d2e1735-e7df-4edc-85cb-04eb35e35d93",
    "form_completion_date": "2011-1-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 45,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d129ebb4-db21-4342-8d9b-318a67aefa56",
    "patient_ID": "TCGA.B5.A0JZ",
    "bcr_drug_barcode": "TCGA-B5-A0JZ-D9977",
    "bcr_drug_uuid": "19fd997d-61c6-4e3f-985a-56bcbc8bd4de",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_dose": 327,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d129ebb4-db21-4342-8d9b-318a67aefa56",
    "patient_ID": "TCGA.B5.A0JZ",
    "bcr_drug_barcode": "TCGA-B5-A0JZ-D9978",
    "bcr_drug_uuid": "e7f62d0f-f14b-4894-89d1-a13ecfb1b6ba",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_dose": 744,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a8079ea5-c37b-4f77-aca0-b043bf420675",
    "patient_ID": "TCGA.B5.A0K2",
    "bcr_drug_barcode": "TCGA-B5-A0K2-D13264",
    "bcr_drug_uuid": "F06CA5D1-8240-44DF-B610-AFD56691F3EA",
    "form_completion_date": "2011-6-22",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 431,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35",
    "patient_ID": "TCGA.B5.A0K3",
    "bcr_drug_barcode": "TCGA-B5-A0K3-D10025",
    "bcr_drug_uuid": "8cc53240-0467-4ac4-bd09-2aa75f382046",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 392,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 330,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35",
    "patient_ID": "TCGA.B5.A0K3",
    "bcr_drug_barcode": "TCGA-B5-A0K3-D10027",
    "bcr_drug_uuid": "3327961e-15b4-4cad-8664-e5146857936a",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 392,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 650,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35",
    "patient_ID": "TCGA.B5.A0K3",
    "bcr_drug_barcode": "TCGA-B5-A0K3-D10028",
    "bcr_drug_uuid": "4acba0b5-93c4-4a5b-9cc0-4e7c5c0d25c3",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL LIPOSOMAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_dose": 70,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35",
    "patient_ID": "TCGA.B5.A0K3",
    "bcr_drug_barcode": "TCGA-B5-A0K3-D10031",
    "bcr_drug_uuid": "0f42fadc-b62a-4916-8c42-c3d5b379e913",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 756,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 798,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 3.8,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35",
    "patient_ID": "TCGA.B5.A0K3",
    "bcr_drug_barcode": "TCGA-B5-A0K3-D10029",
    "bcr_drug_uuid": "72945d62-2fed-4fbb-a6c8-051fd4fe4a70",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 630,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 726,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 410,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a8f38e37-978b-4435-b676-e8d4c34da909",
    "patient_ID": "TCGA.B5.A0K4",
    "bcr_drug_barcode": "TCGA-B5-A0K4-D10033",
    "bcr_drug_uuid": "039fe74c-6161-481c-a8c8-ce504f906bab",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 645,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a8f38e37-978b-4435-b676-e8d4c34da909",
    "patient_ID": "TCGA.B5.A0K4",
    "bcr_drug_barcode": "TCGA-B5-A0K4-D10032",
    "bcr_drug_uuid": "56ad5fb9-7241-463e-ac53-e5fd787dbaae",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 310,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24118b8f-59fe-482a-aed3-7b1bde1571b7",
    "patient_ID": "TCGA.B5.A0K8",
    "bcr_drug_barcode": "TCGA-B5-A0K8-D14631",
    "bcr_drug_uuid": "8065962E-F6EE-43E7-B949-BCBD53A3203A",
    "form_completion_date": "2011-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24118b8f-59fe-482a-aed3-7b1bde1571b7",
    "patient_ID": "TCGA.B5.A0K8",
    "bcr_drug_barcode": "TCGA-B5-A0K8-D14633",
    "bcr_drug_uuid": "5D0C7A49-D765-4DEA-8BB2-A766E664C038",
    "form_completion_date": "2011-8-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e604f5d4-f2c0-4404-9073-b8dbc8396778",
    "patient_ID": "TCGA.B5.A0KB",
    "bcr_drug_barcode": "TCGA-B5-A0KB-D14638",
    "bcr_drug_uuid": "816DA5FA-A6C2-49CC-8A7E-CD75033F3E24",
    "form_completion_date": "2010-4-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_dose": 306,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e604f5d4-f2c0-4404-9073-b8dbc8396778",
    "patient_ID": "TCGA.B5.A0KB",
    "bcr_drug_barcode": "TCGA-B5-A0KB-D14637",
    "bcr_drug_uuid": "31E53917-0886-402B-961D-FB48AFEF60E5",
    "form_completion_date": "2011-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_dose": 480,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e604f5d4-f2c0-4404-9073-b8dbc8396778",
    "patient_ID": "TCGA.B5.A0KB",
    "bcr_drug_barcode": "TCGA-B5-A0KB-D32723",
    "bcr_drug_uuid": "0A852DEC-1FC7-4049-A976-39D6613503CB",
    "form_completion_date": "2012-6-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e604f5d4-f2c0-4404-9073-b8dbc8396778",
    "patient_ID": "TCGA.B5.A0KB",
    "bcr_drug_barcode": "TCGA-B5-A0KB-D32725",
    "bcr_drug_uuid": "16D6AD4D-803D-457C-B2C8-FFB32EF286C5",
    "form_completion_date": "2012-6-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3ea53b15-37f0-446e-a130-6bb2dee56865",
    "patient_ID": "TCGA.B5.A11F",
    "bcr_drug_barcode": "TCGA-B5-A11F-D10043",
    "bcr_drug_uuid": "4fd24910-b142-4cb6-a948-21c6107c9147",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1749,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3411,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dee43082-4aa7-4650-981c-a779e9fe7b55",
    "patient_ID": "TCGA.B5.A11H",
    "bcr_drug_barcode": "TCGA-B5-A11H-D10045",
    "bcr_drug_uuid": "c6410672-c5aa-4f67-8e0d-49f8751fa6f8",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 904,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6d136c7-c250-4361-9fed-50f513959a40",
    "patient_ID": "TCGA.B5.A11I",
    "bcr_drug_barcode": "TCGA-B5-A11I-D10061",
    "bcr_drug_uuid": "21d72cef-f12e-4cda-bd84-747f985c2b46",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 742,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f6d136c7-c250-4361-9fed-50f513959a40",
    "patient_ID": "TCGA.B5.A11I",
    "bcr_drug_barcode": "TCGA-B5-A11I-D10059",
    "bcr_drug_uuid": "39d442bb-e0ac-4863-8f10-b8cd5ec37b16",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 714,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f6d136c7-c250-4361-9fed-50f513959a40",
    "patient_ID": "TCGA.B5.A11I",
    "bcr_drug_barcode": "TCGA-B5-A11I-D10052",
    "bcr_drug_uuid": "5d467755-7d00-4c6c-8bd0-627a3ee80262",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6d136c7-c250-4361-9fed-50f513959a40",
    "patient_ID": "TCGA.B5.A11I",
    "bcr_drug_barcode": "TCGA-B5-A11I-D10054",
    "bcr_drug_uuid": "5f78129b-0086-47a8-babc-2d9920acfdf4",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "af852215-5a4b-44b4-8e8e-b887dcb3cf8c",
    "patient_ID": "TCGA.B5.A11Q",
    "bcr_drug_barcode": "TCGA-B5-A11Q-D10457",
    "bcr_drug_uuid": "e86bffdf-5626-45c4-b9d3-75293e2b2b63",
    "form_completion_date": "2011-4-18",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 529,
    "drug_units": "MG/DAY",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f04befed-6c81-4676-8715-b8c6a33cb9d1",
    "patient_ID": "TCGA.B5.A11R",
    "bcr_drug_barcode": "TCGA-B5-A11R-D10496",
    "bcr_drug_uuid": "b1e0d74a-021c-42d9-a46d-44d38b17ea0a",
    "form_completion_date": "2011-4-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 590,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f04befed-6c81-4676-8715-b8c6a33cb9d1",
    "patient_ID": "TCGA.B5.A11R",
    "bcr_drug_barcode": "TCGA-B5-A11R-D10495",
    "bcr_drug_uuid": "28c1dfe9-c2e5-4406-b17d-7c7f1b13276a",
    "form_completion_date": "2011-4-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 270,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f70a64a8-3faa-468a-a6f3-4815eb01e5a3",
    "patient_ID": "TCGA.B5.A11X",
    "bcr_drug_barcode": "TCGA-B5-A11X-D10576",
    "bcr_drug_uuid": "2ea5fd3a-a820-4c9f-aa76-c94925417011",
    "form_completion_date": "2011-4-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f70a64a8-3faa-468a-a6f3-4815eb01e5a3",
    "patient_ID": "TCGA.B5.A11X",
    "bcr_drug_barcode": "TCGA-B5-A11X-D10580",
    "bcr_drug_uuid": "59182e63-9bb8-43f1-90be-dc0f4a6fe049",
    "form_completion_date": "2011-4-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f70a64a8-3faa-468a-a6f3-4815eb01e5a3",
    "patient_ID": "TCGA.B5.A11X",
    "bcr_drug_barcode": "TCGA-B5-A11X-D10581",
    "bcr_drug_uuid": "c9d6661d-bba4-47c5-80d8-b2992266f842",
    "form_completion_date": "2011-4-21",
    "pharmaceutical_therapy_drug_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f70a64a8-3faa-468a-a6f3-4815eb01e5a3",
    "patient_ID": "TCGA.B5.A11X",
    "bcr_drug_barcode": "TCGA-B5-A11X-D17791",
    "bcr_drug_uuid": "9FB952F0-F1EB-4F69-8864-6026C27DF715",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 412,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_dose": 101,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31884",
    "bcr_drug_uuid": "43FEFFD9-3BED-4A56-9EB1-455708EAC22A",
    "form_completion_date": "2012-5-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2419,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2566,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31911",
    "bcr_drug_uuid": "A162FDC3-D9CD-45C1-86EF-A48917ECF446",
    "form_completion_date": "2012-5-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2419,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2566,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31912",
    "bcr_drug_uuid": "E107830C-1FB2-4D8F-8391-D0B02F4E6617",
    "form_completion_date": "2012-5-10",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2419,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2566,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31924",
    "bcr_drug_uuid": "F7A13179-C253-4373-B251-F5B1E01605A6",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "IXABEPILONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2825,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2830,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31925",
    "bcr_drug_uuid": "7DF45FB4-56F8-4FAE-ABC2-84AB51BA8561",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2916,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2985,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9",
    "patient_ID": "TCGA.B5.A1MS",
    "bcr_drug_barcode": "TCGA-B5-A1MS-D31928",
    "bcr_drug_uuid": "F0CD5E1C-529C-4907-98B2-99C60A7D2153",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3041,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3090,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5261330-596e-4632-a5a3-8d3a2aa5de38",
    "patient_ID": "TCGA.B5.A1MU",
    "bcr_drug_barcode": "TCGA-B5-A1MU-D14405",
    "bcr_drug_uuid": "A71E75E7-A2C1-4D9C-93F4-EBF3E531705A",
    "form_completion_date": "2011-7-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1550,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "37bac6ba-be93-42cc-892b-efd0bdb850bd",
    "patient_ID": "TCGA.B5.A1MX",
    "bcr_drug_barcode": "TCGA-B5-A1MX-D21623",
    "bcr_drug_uuid": "73F50EDD-34FA-4E17-93BC-17ADEC3AE898",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4",
    "patient_ID": "TCGA.B5.A1MY",
    "bcr_drug_barcode": "TCGA-B5-A1MY-D21849",
    "bcr_drug_uuid": "FF007808-6CF7-4F5D-9422-4544402E0CC8",
    "form_completion_date": "2012-2-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4",
    "patient_ID": "TCGA.B5.A1MY",
    "bcr_drug_barcode": "TCGA-B5-A1MY-D21850",
    "bcr_drug_uuid": "D6FE1A69-61DA-4D8A-954A-AF6CA6FE3F91",
    "form_completion_date": "2012-2-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 645,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d79e692c-5053-4484-a180-01a094c5ff45",
    "patient_ID": "TCGA.B5.A1N2",
    "bcr_drug_barcode": "TCGA-B5-A1N2-D21945",
    "bcr_drug_uuid": "41CBE845-6D3F-4CB6-B530-20210A51FAE3",
    "form_completion_date": "2012-2-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d79e692c-5053-4484-a180-01a094c5ff45",
    "patient_ID": "TCGA.B5.A1N2",
    "bcr_drug_barcode": "TCGA-B5-A1N2-D21948",
    "bcr_drug_uuid": "21EAFBDE-B19F-483B-90C5-247001382A73",
    "form_completion_date": "2012-2-22",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "EEB327B4-B705-4161-BA94-647F0E14F5B4",
    "patient_ID": "TCGA.B5.A3FD",
    "bcr_drug_barcode": "TCGA-B5-A3FD-D29599",
    "bcr_drug_uuid": "95ACDEC1-15D5-43AF-9374-067DAB5E44F9",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 677,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "EEB327B4-B705-4161-BA94-647F0E14F5B4",
    "patient_ID": "TCGA.B5.A3FD",
    "bcr_drug_barcode": "TCGA-B5-A3FD-D29600",
    "bcr_drug_uuid": "F87C9D59-FFD7-4609-8C44-C1CE6BEBF459",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 677,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "EEB327B4-B705-4161-BA94-647F0E14F5B4",
    "patient_ID": "TCGA.B5.A3FD",
    "bcr_drug_barcode": "TCGA-B5-A3FD-D29601",
    "bcr_drug_uuid": "5F380371-BC1C-48BB-95AD-5EA12F60DFC8",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_dose": 1641,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3789AE3F-286B-42F0-A805-320AD69EA1DF",
    "patient_ID": "TCGA.B5.A3S1",
    "bcr_drug_barcode": "TCGA-B5-A3S1-D31852",
    "bcr_drug_uuid": "147A54EA-492E-4A27-A55E-7BC9DB6772A5",
    "form_completion_date": "2012-5-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3789AE3F-286B-42F0-A805-320AD69EA1DF",
    "patient_ID": "TCGA.B5.A3S1",
    "bcr_drug_barcode": "TCGA-B5-A3S1-D31858",
    "bcr_drug_uuid": "FA0A3E62-B062-4EE1-A5FA-569616F4AB85",
    "form_completion_date": "2012-5-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AE8A4958-5407-4C01-93C3-8090862533AE",
    "patient_ID": "TCGA.B5.A5OC",
    "bcr_drug_barcode": "TCGA-B5-A5OC-D57491",
    "bcr_drug_uuid": "707CBBF9-1168-471B-B062-BD3EE6D6EFC4",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E240DC0-80B7-41EA-81B3-33ECE2753C2B",
    "patient_ID": "TCGA.B5.A5OD",
    "bcr_drug_barcode": "TCGA-B5-A5OD-D57494",
    "bcr_drug_uuid": "61092754-F123-4C1F-9A7F-A72250CC9CF5",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 241,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E240DC0-80B7-41EA-81B3-33ECE2753C2B",
    "patient_ID": "TCGA.B5.A5OD",
    "bcr_drug_barcode": "TCGA-B5-A5OD-D57495",
    "bcr_drug_uuid": "8BC4F48F-5147-4B4A-A7CC-7224CE2BCA06",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 241,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA",
    "patient_ID": "TCGA.B5.A5OE",
    "bcr_drug_barcode": "TCGA-B5-A5OE-D57493",
    "bcr_drug_uuid": "A2FF1F4B-59BC-4134-AC17-EF754BA0E5A0",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA",
    "patient_ID": "TCGA.B5.A5OE",
    "bcr_drug_barcode": "TCGA-B5-A5OE-D57498",
    "bcr_drug_uuid": "9BE70ADA-2CF5-4D10-84F2-42FE1F381A1C",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "IXABEPILONE",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA",
    "patient_ID": "TCGA.B5.A5OE",
    "bcr_drug_barcode": "TCGA-B5-A5OE-D57500",
    "bcr_drug_uuid": "F3F82874-CC18-43CC-971E-8ED77CA14042",
    "form_completion_date": "2014-3-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "73e5310d-ba8c-4cbc-aa4f-e06206f898f4",
    "patient_ID": "TCGA.BG.A0M4",
    "bcr_drug_barcode": "TCGA-BG-A0M4-D4431",
    "bcr_drug_uuid": "f2fe21b4-b4fe-4f9f-a5b8-80252a9a192f",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73e5310d-ba8c-4cbc-aa4f-e06206f898f4",
    "patient_ID": "TCGA.BG.A0M4",
    "bcr_drug_barcode": "TCGA-BG-A0M4-D4432",
    "bcr_drug_uuid": "34bf5fe4-0e4e-4e3e-87f5-f6368bcffd28",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "002724fa-7051-49fa-9c58-4bcb7eba4ac6",
    "patient_ID": "TCGA.BG.A0M6",
    "bcr_drug_barcode": "TCGA-BG-A0M6-D4438",
    "bcr_drug_uuid": "53ba7291-b291-46f5-9234-8252d59d1b3d",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 450,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2280
  },
  {
    "bcr_patient_uuid": "002724fa-7051-49fa-9c58-4bcb7eba4ac6",
    "patient_ID": "TCGA.BG.A0M6",
    "bcr_drug_barcode": "TCGA-BG-A0M6-D4439",
    "bcr_drug_uuid": "b4cf6c89-a536-4617-abae-c5e112a5dd9c",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1545
  },
  {
    "bcr_patient_uuid": "1d9c2113-ddcb-4440-89c3-cd21cee6d401",
    "patient_ID": "TCGA.BG.A0M7",
    "bcr_drug_barcode": "TCGA-BG-A0M7-D4459",
    "bcr_drug_uuid": "5cbee9b0-2fe9-4124-9b70-6ef9a46ad460",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "1d9c2113-ddcb-4440-89c3-cd21cee6d401",
    "patient_ID": "TCGA.BG.A0M7",
    "bcr_drug_barcode": "TCGA-BG-A0M7-D4453",
    "bcr_drug_uuid": "c741932c-f86c-4808-ad00-4606adf82f21",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 868,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1d9c2113-ddcb-4440-89c3-cd21cee6d401",
    "patient_ID": "TCGA.BG.A0M7",
    "bcr_drug_barcode": "TCGA-BG-A0M7-D4454",
    "bcr_drug_uuid": "26201aa1-78ed-4881-a5a7-884357da7b06",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "1d9c2113-ddcb-4440-89c3-cd21cee6d401",
    "patient_ID": "TCGA.BG.A0M7",
    "bcr_drug_barcode": "TCGA-BG-A0M7-D4455",
    "bcr_drug_uuid": "b23ebd35-dcb7-465d-8ebf-d76839dc1fa9",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a798a8cc-4e72-4a8c-9e20-74a14deafd12",
    "patient_ID": "TCGA.BG.A0MS",
    "bcr_drug_barcode": "TCGA-BG-A0MS-D4643",
    "bcr_drug_uuid": "36b4da84-bc54-4f9c-8232-48475357f712",
    "form_completion_date": "2010-12-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 290,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1740
  },
  {
    "bcr_patient_uuid": "a798a8cc-4e72-4a8c-9e20-74a14deafd12",
    "patient_ID": "TCGA.BG.A0MS",
    "bcr_drug_barcode": "TCGA-BG-A0MS-D4642",
    "bcr_drug_uuid": "5160eb08-acf6-4632-90f7-162ce68a365e",
    "form_completion_date": "2010-12-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "a7329910-b1c7-4a18-b28e-8fad79121339",
    "patient_ID": "TCGA.BG.A0MU",
    "bcr_drug_barcode": "TCGA-BG-A0MU-D4661",
    "bcr_drug_uuid": "f2348be2-8d4e-4785-9289-5230f91bd122",
    "form_completion_date": "2010-12-9",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "cc058b8c-df40-4f9e-88e3-3d1131b22b41",
    "patient_ID": "TCGA.BG.A0VT",
    "bcr_drug_barcode": "TCGA-BG-A0VT-D55425",
    "bcr_drug_uuid": "D3FA983D-287C-4BC0-A71D-B0A408AA2406",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc058b8c-df40-4f9e-88e3-3d1131b22b41",
    "patient_ID": "TCGA.BG.A0VT",
    "bcr_drug_barcode": "TCGA-BG-A0VT-D55548",
    "bcr_drug_uuid": "02BC066A-E639-44C6-B309-2E8119F2428B",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "edee2bf5-284c-4d77-823a-d037fe4c4b9e",
    "patient_ID": "TCGA.BG.A0VZ",
    "bcr_drug_barcode": "TCGA-BG-A0VZ-D34093",
    "bcr_drug_uuid": "CEBA52A4-E390-4A1F-A816-2DF5419FCC62",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "edee2bf5-284c-4d77-823a-d037fe4c4b9e",
    "patient_ID": "TCGA.BG.A0VZ",
    "bcr_drug_barcode": "TCGA-BG-A0VZ-D34126",
    "bcr_drug_uuid": "F90FD7F2-A96B-40EC-BA0F-597E495ABEFE",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "edee2bf5-284c-4d77-823a-d037fe4c4b9e",
    "patient_ID": "TCGA.BG.A0VZ",
    "bcr_drug_barcode": "TCGA-BG-A0VZ-D34094",
    "bcr_drug_uuid": "2F1E7C63-DC90-45FC-8369-C60AB386FDAE",
    "form_completion_date": "2014-5-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f384eb3f-92ab-4327-87eb-45b5f72a1580",
    "patient_ID": "TCGA.BG.A2AE",
    "bcr_drug_barcode": "TCGA-BG-A2AE-D56535",
    "bcr_drug_uuid": "B2C5C7D7-A0FB-47E6-9AB8-A7A7FF20033A",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f384eb3f-92ab-4327-87eb-45b5f72a1580",
    "patient_ID": "TCGA.BG.A2AE",
    "bcr_drug_barcode": "TCGA-BG-A2AE-D56536",
    "bcr_drug_uuid": "FFCED0E8-5EDD-4DFA-BEF9-3A40085BEF56",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f384eb3f-92ab-4327-87eb-45b5f72a1580",
    "patient_ID": "TCGA.BG.A2AE",
    "bcr_drug_barcode": "TCGA-BG-A2AE-D56539",
    "bcr_drug_uuid": "BAB8CA9B-473B-4FAA-BE89-AA4154331DDF",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "214A09BB-CE52-4055-B036-065E8CB7AC7D",
    "patient_ID": "TCGA.BG.A2L7",
    "bcr_drug_barcode": "TCGA-BG-A2L7-D63225",
    "bcr_drug_uuid": "32E13037-A275-4FAC-8D36-32FDD3E2958A",
    "form_completion_date": "2014-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F92080F-F6E0-42DB-A02B-B3069664F6D0",
    "patient_ID": "TCGA.BG.A3PP",
    "bcr_drug_barcode": "TCGA-BG-A3PP-D33394",
    "bcr_drug_uuid": "5513F425-D8FE-44B8-A61A-D3577405C74D",
    "form_completion_date": "2012-7-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F92080F-F6E0-42DB-A02B-B3069664F6D0",
    "patient_ID": "TCGA.BG.A3PP",
    "bcr_drug_barcode": "TCGA-BG-A3PP-D33395",
    "bcr_drug_uuid": "A9469417-2AD1-4220-92EB-AEAEC9FCA5A0",
    "form_completion_date": "2012-7-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "51bd85e2-2c60-4654-bfcb-83dccef8964b",
    "patient_ID": "TCGA.BK.A0CA",
    "bcr_drug_barcode": "TCGA-BK-A0CA-D7333",
    "bcr_drug_uuid": "8aaa4779-eb73-4e90-953d-abb1ad2c5d14",
    "form_completion_date": "2011-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3329
  },
  {
    "bcr_patient_uuid": "51bd85e2-2c60-4654-bfcb-83dccef8964b",
    "patient_ID": "TCGA.BK.A0CA",
    "bcr_drug_barcode": "TCGA-BK-A0CA-D7335",
    "bcr_drug_uuid": "bb5254bc-7922-4b42-bcf6-c77c8051c3be",
    "form_completion_date": "2011-2-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 108,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 756
  },
  {
    "bcr_patient_uuid": "59e9029a-8ddd-4447-b35a-72bc39f82a30",
    "patient_ID": "TCGA.BK.A0CB",
    "bcr_drug_barcode": "TCGA-BK-A0CB-D3364",
    "bcr_drug_uuid": "88449524-c3b5-45fb-8f1b-11c71db21227",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3216
  },
  {
    "bcr_patient_uuid": "59e9029a-8ddd-4447-b35a-72bc39f82a30",
    "patient_ID": "TCGA.BK.A0CB",
    "bcr_drug_barcode": "TCGA-BK-A0CB-D3362",
    "bcr_drug_uuid": "a9ed4b47-70bb-44f4-9002-cb13ef22ce93",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "2b865f8c-539f-4cb2-8f08-41709e9511e5",
    "patient_ID": "TCGA.BK.A0CC",
    "bcr_drug_barcode": "TCGA-BK-A0CC-D5132",
    "bcr_drug_uuid": "1e9dca3a-cf48-46bd-8a4d-eba28f86e28d",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2592
  },
  {
    "bcr_patient_uuid": "2b865f8c-539f-4cb2-8f08-41709e9511e5",
    "patient_ID": "TCGA.BK.A0CC",
    "bcr_drug_barcode": "TCGA-BK-A0CC-D5133",
    "bcr_drug_uuid": "bc56e92c-5de8-431d-8c2c-f166cad0fef9",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1795
  },
  {
    "bcr_patient_uuid": "ab7adf74-6e87-4117-9742-54e323348e06",
    "patient_ID": "TCGA.BK.A26L",
    "bcr_drug_barcode": "TCGA-BK-A26L-D21627",
    "bcr_drug_uuid": "CB3D1C5F-2A68-45FF-9103-D3D4836586D9",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4153
  },
  {
    "bcr_patient_uuid": "ab7adf74-6e87-4117-9742-54e323348e06",
    "patient_ID": "TCGA.BK.A26L",
    "bcr_drug_barcode": "TCGA-BK-A26L-D21628",
    "bcr_drug_uuid": "F01F265D-9735-45F5-BD86-FED282F0CE51",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1716
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9197",
    "bcr_drug_uuid": "17C332DF-4325-481E-93E3-62F4C28621D6",
    "form_completion_date": "2005-11-19",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 950,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 979,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9202",
    "bcr_drug_uuid": "68D19299-AC67-45AB-B2EC-6253658DBC74",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1379,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 167,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1336
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9204",
    "bcr_drug_uuid": "206C8C36-2556-4487-9710-60417CC2C5D3",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1379,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9189",
    "bcr_drug_uuid": "BB80C36C-8DB6-4626-83DA-781EAD0EB5E2",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 45,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9203",
    "bcr_drug_uuid": "155CDE0C-FE49-4755-B0EE-70E287E214DD",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1379,
    "drug_cycles": 8,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 15,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9200",
    "bcr_drug_uuid": "48905B00-83FE-4CF2-9A40-D8FEEF537236",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1243,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9193",
    "bcr_drug_uuid": "AA1BADFE-9F43-492F-A107-DE4DCDABC947",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9199",
    "bcr_drug_uuid": "FB52775E-0E9B-45CA-B849-FBA324FB71E9",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1072,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1243,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 2000,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9198",
    "bcr_drug_uuid": "54C38DE3-026D-4CEC-9C6A-D9E4C807EA68",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1072,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1243,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9196",
    "bcr_drug_uuid": "8A0D65E9-3AA3-44C2-AAED-5E3CBAD3767C",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1280
  },
  {
    "bcr_patient_uuid": "4eb95566-0e73-4260-853e-f7df650667a0",
    "patient_ID": "TCGA.BS.A0T9",
    "bcr_drug_barcode": "TCGA-BS-A0T9-D9201",
    "bcr_drug_uuid": "67441C30-FDAF-49E6-AAD8-E4D349C349EC",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1163,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1250,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 1000,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "ad3d8420-f562-4cbe-ac82-c968bd4f782d",
    "patient_ID": "TCGA.BS.A0TA",
    "bcr_drug_barcode": "TCGA-BS-A0TA-D4427",
    "bcr_drug_uuid": "5b141563-72d2-4c1a-8f65-9a0aadb3dd69",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 621,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3726
  },
  {
    "bcr_patient_uuid": "ad3d8420-f562-4cbe-ac82-c968bd4f782d",
    "patient_ID": "TCGA.BS.A0TA",
    "bcr_drug_barcode": "TCGA-BS-A0TA-D4428",
    "bcr_drug_uuid": "124359ef-3b9c-4a36-b96a-5f62eed7ba12",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 455,
    "days_to_drug_end": 554,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "ad3d8420-f562-4cbe-ac82-c968bd4f782d",
    "patient_ID": "TCGA.BS.A0TA",
    "bcr_drug_barcode": "TCGA-BS-A0TA-D4429",
    "bcr_drug_uuid": "8720963f-1263-4749-9917-a825e2546d44",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 455,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 40,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "ad3d8420-f562-4cbe-ac82-c968bd4f782d",
    "patient_ID": "TCGA.BS.A0TA",
    "bcr_drug_barcode": "TCGA-BS-A0TA-D4426",
    "bcr_drug_uuid": "c2c27c9f-7696-4311-aaf0-fcf3e21ad592",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba",
    "patient_ID": "TCGA.BS.A0TE",
    "bcr_drug_barcode": "TCGA-BS-A0TE-D4414",
    "bcr_drug_uuid": "3b4e361b-6998-4d61-a37c-3b7cc45e100c",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba",
    "patient_ID": "TCGA.BS.A0TE",
    "bcr_drug_barcode": "TCGA-BS-A0TE-D4412",
    "bcr_drug_uuid": "50d4af36-43de-40f0-84ae-5e54d76767cc",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba",
    "patient_ID": "TCGA.BS.A0TE",
    "bcr_drug_barcode": "TCGA-BS-A0TE-D4415",
    "bcr_drug_uuid": "14e0a185-5a8c-4e00-b7b9-6121f2e8475e",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 308,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 924
  },
  {
    "bcr_patient_uuid": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba",
    "patient_ID": "TCGA.BS.A0TE",
    "bcr_drug_barcode": "TCGA-BS-A0TE-D4417",
    "bcr_drug_uuid": "22ca9dc4-3e42-424d-bc67-314453cbb49d",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba",
    "patient_ID": "TCGA.BS.A0TE",
    "bcr_drug_barcode": "TCGA-BS-A0TE-D4409",
    "bcr_drug_uuid": "9f6de715-e2ef-462c-adf2-eb96c3db806e",
    "form_completion_date": "2010-11-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 45,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "fb7475df-30cc-4316-b9ac-37cbeeb6ba2b",
    "patient_ID": "TCGA.BS.A0U8",
    "bcr_drug_barcode": "TCGA-BS-A0U8-D16706",
    "bcr_drug_uuid": "BE495E20-217E-4C80-8B5F-547447ACA4E1",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 89,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 534
  },
  {
    "bcr_patient_uuid": "fb7475df-30cc-4316-b9ac-37cbeeb6ba2b",
    "patient_ID": "TCGA.BS.A0U8",
    "bcr_drug_barcode": "TCGA-BS-A0U8-D16707",
    "bcr_drug_uuid": "C619C938-E981-4DAC-9ACA-62EE09AD5538",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 99,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 594
  },
  {
    "bcr_patient_uuid": "a7c565fc-c711-4b63-9549-4cd74d1f57c2",
    "patient_ID": "TCGA.BS.A0UM",
    "bcr_drug_barcode": "TCGA-BS-A0UM-D17018",
    "bcr_drug_uuid": "ED9501A7-633C-45DC-9123-F634D931B33E",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1530,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1658,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 96,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METS TO LUNG AND BRAIN",
    "drug_total_dose": 576
  },
  {
    "bcr_patient_uuid": "a7c565fc-c711-4b63-9549-4cd74d1f57c2",
    "patient_ID": "TCGA.BS.A0UM",
    "bcr_drug_barcode": "TCGA-BS-A0UM-D17021",
    "bcr_drug_uuid": "4B475BA7-94AB-4EB6-9667-109F90A34520",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1890,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2050,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METS TO LUNG AND BRAIN",
    "drug_total_dose": 2550
  },
  {
    "bcr_patient_uuid": "a7c565fc-c711-4b63-9549-4cd74d1f57c2",
    "patient_ID": "TCGA.BS.A0UM",
    "bcr_drug_barcode": "TCGA-BS-A0UM-D17020",
    "bcr_drug_uuid": "CDEE1CDD-6098-4B49-BC89-B533208F4495",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1890,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2050,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 2,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METS TO LUNG AND BRAIN",
    "drug_total_dose": 1870
  },
  {
    "bcr_patient_uuid": "a7c565fc-c711-4b63-9549-4cd74d1f57c2",
    "patient_ID": "TCGA.BS.A0UM",
    "bcr_drug_barcode": "TCGA-BS-A0UM-D17019",
    "bcr_drug_uuid": "A828F076-8365-4401-B33F-6CA68CAC2EC2",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1552,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1659,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 307,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METS TO LUNG AND BRAIN",
    "drug_total_dose": 1842
  },
  {
    "bcr_patient_uuid": "a7c565fc-c711-4b63-9549-4cd74d1f57c2",
    "patient_ID": "TCGA.BS.A0UM",
    "bcr_drug_barcode": "TCGA-BS-A0UM-D17017",
    "bcr_drug_uuid": "D170BBDE-7E45-4B1E-A301-7261A9E04A2E",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1530,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1658,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 86,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METS TO LUNG AND BRAIN",
    "drug_total_dose": 516
  },
  {
    "bcr_patient_uuid": "ac216bb5-15e4-4462-955e-8a522380690e",
    "patient_ID": "TCGA.D1.A0ZP",
    "bcr_drug_barcode": "TCGA-D1-A0ZP-D17746",
    "bcr_drug_uuid": "BC0B0861-044C-44C8-9A65-C27853DA6546",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "ac216bb5-15e4-4462-955e-8a522380690e",
    "patient_ID": "TCGA.D1.A0ZP",
    "bcr_drug_barcode": "TCGA-D1-A0ZP-D17765",
    "bcr_drug_uuid": "E5E62438-A5E6-46EE-BE4B-F5502C224D88",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 818,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 861,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "ac216bb5-15e4-4462-955e-8a522380690e",
    "patient_ID": "TCGA.D1.A0ZP",
    "bcr_drug_barcode": "TCGA-D1-A0ZP-D17763",
    "bcr_drug_uuid": "DB9DEDD6-554A-4C0F-9865-DBD79FF8DB69",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4180
  },
  {
    "bcr_patient_uuid": "ac216bb5-15e4-4462-955e-8a522380690e",
    "patient_ID": "TCGA.D1.A0ZP",
    "bcr_drug_barcode": "TCGA-D1-A0ZP-D17764",
    "bcr_drug_uuid": "5107CB4B-9E22-4A3B-A7E3-A002A97645CA",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 818,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 861,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 45,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "d74bc72e-8103-4aed-8958-5f40953d48eb",
    "patient_ID": "TCGA.D1.A0ZU",
    "bcr_drug_barcode": "TCGA-D1-A0ZU-D17815",
    "bcr_drug_uuid": "CC7B2E87-3F9D-4964-A803-4E0FE36DA4FC",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5410
  },
  {
    "bcr_patient_uuid": "d74bc72e-8103-4aed-8958-5f40953d48eb",
    "patient_ID": "TCGA.D1.A0ZU",
    "bcr_drug_barcode": "TCGA-D1-A0ZU-D17777",
    "bcr_drug_uuid": "9AF71B83-C5F5-455D-8C8B-451DC48CBF0E",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2260
  },
  {
    "bcr_patient_uuid": "4d3af3af-24f4-415a-9677-20b0f366a102",
    "patient_ID": "TCGA.D1.A0ZZ",
    "bcr_drug_barcode": "TCGA-D1-A0ZZ-D17767",
    "bcr_drug_uuid": "DE6692C2-B1CD-42A2-B743-26B088F0B528",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1690
  },
  {
    "bcr_patient_uuid": "4d3af3af-24f4-415a-9677-20b0f366a102",
    "patient_ID": "TCGA.D1.A0ZZ",
    "bcr_drug_barcode": "TCGA-D1-A0ZZ-D17766",
    "bcr_drug_uuid": "7BDF8720-A328-4E86-9777-90BF9EF85590",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "f7010b87-a559-4501-99f9-0fcca1e986e1",
    "patient_ID": "TCGA.D1.A15V",
    "bcr_drug_barcode": "TCGA-D1-A15V-D18461",
    "bcr_drug_uuid": "25E2D870-8181-411F-ADF2-661D6FA298BB",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2060
  },
  {
    "bcr_patient_uuid": "f7010b87-a559-4501-99f9-0fcca1e986e1",
    "patient_ID": "TCGA.D1.A15V",
    "bcr_drug_barcode": "TCGA-D1-A15V-D18459",
    "bcr_drug_uuid": "BC787F87-F7BF-4229-9076-00F797B0A88C",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1210
  },
  {
    "bcr_patient_uuid": "d6562acf-6d82-4f08-a779-82cdc5df16f9",
    "patient_ID": "TCGA.D1.A15W",
    "bcr_drug_barcode": "TCGA-D1-A15W-D18471",
    "bcr_drug_uuid": "2292484D-E393-49AF-BA2F-35757DA620B0",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "d6562acf-6d82-4f08-a779-82cdc5df16f9",
    "patient_ID": "TCGA.D1.A15W",
    "bcr_drug_barcode": "TCGA-D1-A15W-D18472",
    "bcr_drug_uuid": "3D92959A-B80D-40AE-9876-AEAA751BF22B",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "a438dce7-6592-4ea6-a401-57f5a8fe8ba6",
    "patient_ID": "TCGA.D1.A163",
    "bcr_drug_barcode": "TCGA-D1-A163-D18492",
    "bcr_drug_uuid": "50C6FF80-1A38-4912-B8FD-3594B695CD4D",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5360
  },
  {
    "bcr_patient_uuid": "a438dce7-6592-4ea6-a401-57f5a8fe8ba6",
    "patient_ID": "TCGA.D1.A163",
    "bcr_drug_barcode": "TCGA-D1-A163-D18491",
    "bcr_drug_uuid": "AF0313ED-CB28-462D-9B55-221511D98B16",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2490
  },
  {
    "bcr_patient_uuid": "9a599f57-0e8d-4e1f-a181-791f5fdeadb7",
    "patient_ID": "TCGA.D1.A169",
    "bcr_drug_barcode": "TCGA-D1-A169-D18507",
    "bcr_drug_uuid": "4052EEE4-7A2B-4F9A-B0D5-AF2690B6B207",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 533,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 554,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1140
  },
  {
    "bcr_patient_uuid": "9a599f57-0e8d-4e1f-a181-791f5fdeadb7",
    "patient_ID": "TCGA.D1.A169",
    "bcr_drug_barcode": "TCGA-D1-A169-D18504",
    "bcr_drug_uuid": "133948C9-1498-4CE2-A251-FC5175D9E7FC",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2170
  },
  {
    "bcr_patient_uuid": "9a599f57-0e8d-4e1f-a181-791f5fdeadb7",
    "patient_ID": "TCGA.D1.A169",
    "bcr_drug_barcode": "TCGA-D1-A169-D18505",
    "bcr_drug_uuid": "A64EB640-7430-4051-8C26-6BE57A93DDE5",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3730
  },
  {
    "bcr_patient_uuid": "9a599f57-0e8d-4e1f-a181-791f5fdeadb7",
    "patient_ID": "TCGA.D1.A169",
    "bcr_drug_barcode": "TCGA-D1-A169-D18506",
    "bcr_drug_uuid": "0DD9BDF7-F858-492D-9510-B1888D905355",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 533,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1135,
    "drug_cycles": 29,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10300
  },
  {
    "bcr_patient_uuid": "5693302a-4548-4c0b-8725-0cb7c67bc4f8",
    "patient_ID": "TCGA.D1.A16D",
    "bcr_drug_barcode": "TCGA-D1-A16D-D18511",
    "bcr_drug_uuid": "3033158E-C662-44F6-982F-CBA1C043E1A4",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2150
  },
  {
    "bcr_patient_uuid": "5693302a-4548-4c0b-8725-0cb7c67bc4f8",
    "patient_ID": "TCGA.D1.A16D",
    "bcr_drug_barcode": "TCGA-D1-A16D-D19217",
    "bcr_drug_uuid": "9AF0DBA5-CC62-4BF5-9F51-BC53D5FE53C6",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10030
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18565",
    "bcr_drug_uuid": "7C4CB5B1-9B06-4F93-BDEC-3A3F515D68A7",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18567",
    "bcr_drug_uuid": "BE17FEDF-56A8-4134-921E-58528878FFC5",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18566",
    "bcr_drug_uuid": "648CE469-6E81-48CA-91B7-E77B3A266EC4",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18563",
    "bcr_drug_uuid": "4DD63899-10C7-45B4-8257-9B295D593212",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18570",
    "bcr_drug_uuid": "F5DC0735-DDEB-4739-80C6-BA9BF7409378",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 651,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 756,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1470
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18572",
    "bcr_drug_uuid": "AA576AAB-1F6C-4270-BD41-EF8F279A28F5",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 794,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 822,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 145
  },
  {
    "bcr_patient_uuid": "16e69011-c295-479f-b521-86e66fba498d",
    "patient_ID": "TCGA.D1.A16G",
    "bcr_drug_barcode": "TCGA-D1-A16G-D18571",
    "bcr_drug_uuid": "A18B297E-2A43-4DF5-ABC9-8A21110DA904",
    "form_completion_date": "2011-11-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 651,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 756,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2770
  },
  {
    "bcr_patient_uuid": "4db4d048-016a-4186-a519-bfbad237762f",
    "patient_ID": "TCGA.D1.A16J",
    "bcr_drug_barcode": "TCGA-D1-A16J-D18581",
    "bcr_drug_uuid": "E4A7D04B-2F5D-425B-A0EF-A65584082BAF",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2630
  },
  {
    "bcr_patient_uuid": "4db4d048-016a-4186-a519-bfbad237762f",
    "patient_ID": "TCGA.D1.A16J",
    "bcr_drug_barcode": "TCGA-D1-A16J-D18583",
    "bcr_drug_uuid": "4B0D4AA1-F07A-47EB-A857-10CE3C2E7A4A",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5160
  },
  {
    "bcr_patient_uuid": "dbbbddae-d711-40f5-bd10-863735885b1f",
    "patient_ID": "TCGA.D1.A16N",
    "bcr_drug_barcode": "TCGA-D1-A16N-D18601",
    "bcr_drug_uuid": "09EC40B7-2CBC-4AB9-B22A-F578D1E4AF80",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "dbbbddae-d711-40f5-bd10-863735885b1f",
    "patient_ID": "TCGA.D1.A16N",
    "bcr_drug_barcode": "TCGA-D1-A16N-D18603",
    "bcr_drug_uuid": "E4E94708-5281-4C69-AAC1-95FCD8302533",
    "form_completion_date": "2011-11-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 710
  },
  {
    "bcr_patient_uuid": "f0b3ab10-43f8-48a8-b460-66ceaaf637db",
    "patient_ID": "TCGA.D1.A175",
    "bcr_drug_barcode": "TCGA-D1-A175-D20247",
    "bcr_drug_uuid": "1772B18B-7A14-401D-8F0B-8C0E259E41AC",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "f0b3ab10-43f8-48a8-b460-66ceaaf637db",
    "patient_ID": "TCGA.D1.A175",
    "bcr_drug_barcode": "TCGA-D1-A175-D20262",
    "bcr_drug_uuid": "29CCCE34-B8D7-406A-BD61-808B048A6C06",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2190
  },
  {
    "bcr_patient_uuid": "37d5c1d9-3ff5-44fe-afdc-ff430a0f3510",
    "patient_ID": "TCGA.D1.A179",
    "bcr_drug_barcode": "TCGA-D1-A179-D20306",
    "bcr_drug_uuid": "37FCE18F-E99F-4D1B-A170-77064939900B",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3124
  },
  {
    "bcr_patient_uuid": "37d5c1d9-3ff5-44fe-afdc-ff430a0f3510",
    "patient_ID": "TCGA.D1.A179",
    "bcr_drug_barcode": "TCGA-D1-A179-D20305",
    "bcr_drug_uuid": "664E8458-557E-489A-8614-B8A0F19B7AD6",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2170
  },
  {
    "bcr_patient_uuid": "7ddeddd1-b2ad-425f-94a2-9c476b959f2a",
    "patient_ID": "TCGA.D1.A17D",
    "bcr_drug_barcode": "TCGA-D1-A17D-D20257",
    "bcr_drug_uuid": "599ED21D-AC9B-4B32-A4C4-F956E7CAC160",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 920
  },
  {
    "bcr_patient_uuid": "7ddeddd1-b2ad-425f-94a2-9c476b959f2a",
    "patient_ID": "TCGA.D1.A17D",
    "bcr_drug_barcode": "TCGA-D1-A17D-D20260",
    "bcr_drug_uuid": "435FBACA-1842-4FF2-8386-80A434112D7B",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2010
  },
  {
    "bcr_patient_uuid": "6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b",
    "patient_ID": "TCGA.D1.A17U",
    "bcr_drug_barcode": "TCGA-D1-A17U-D20298",
    "bcr_drug_uuid": "8A428A3C-A6D9-4187-8C7E-3EE1A4778A4D",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2610
  },
  {
    "bcr_patient_uuid": "6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b",
    "patient_ID": "TCGA.D1.A17U",
    "bcr_drug_barcode": "TCGA-D1-A17U-D20297",
    "bcr_drug_uuid": "FD64482C-545F-40F5-A539-428A2A1F1FBC",
    "form_completion_date": "2012-1-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "e56491af-718f-4ca1-b3cd-0e5b3154697b",
    "patient_ID": "TCGA.D1.A1NU",
    "bcr_drug_barcode": "TCGA-D1-A1NU-D21640",
    "bcr_drug_uuid": "B9E6E368-84B3-4941-A01A-CDC9D94D1C86",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "e56491af-718f-4ca1-b3cd-0e5b3154697b",
    "patient_ID": "TCGA.D1.A1NU",
    "bcr_drug_barcode": "TCGA-D1-A1NU-D21641",
    "bcr_drug_uuid": "EDCB855A-36CF-46CC-91F0-770C9809A095",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1320
  },
  {
    "bcr_patient_uuid": "df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9",
    "patient_ID": "TCGA.D1.A1NX",
    "bcr_drug_barcode": "TCGA-D1-A1NX-D21568",
    "bcr_drug_uuid": "665DD22F-F8F1-49CE-98F9-1FD5F839FA26",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1980
  },
  {
    "bcr_patient_uuid": "df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9",
    "patient_ID": "TCGA.D1.A1NX",
    "bcr_drug_barcode": "TCGA-D1-A1NX-D21569",
    "bcr_drug_uuid": "D301630E-F403-4E02-9FB9-DDC1AA6936D5",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3060
  },
  {
    "bcr_patient_uuid": "0a9faff7-ec4d-4b5a-aa83-6fa358f72074",
    "patient_ID": "TCGA.D1.A1NY",
    "bcr_drug_barcode": "TCGA-D1-A1NY-D21630",
    "bcr_drug_uuid": "6ED78C74-6DD4-492A-A5D4-813FF4A2D998",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2220
  },
  {
    "bcr_patient_uuid": "0a9faff7-ec4d-4b5a-aa83-6fa358f72074",
    "patient_ID": "TCGA.D1.A1NY",
    "bcr_drug_barcode": "TCGA-D1-A1NY-D21631",
    "bcr_drug_uuid": "1922F72C-649F-41D3-97E6-A83F2427C6A3",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3620
  },
  {
    "bcr_patient_uuid": "E17A5FCA-616C-4A74-ABE7-778539ECDC0B",
    "patient_ID": "TCGA.D1.A3DA",
    "bcr_drug_barcode": "TCGA-D1-A3DA-D41462",
    "bcr_drug_uuid": "1135FE1C-5304-452B-A439-4E4735D58A88",
    "form_completion_date": "2015-5-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E17A5FCA-616C-4A74-ABE7-778539ECDC0B",
    "patient_ID": "TCGA.D1.A3DA",
    "bcr_drug_barcode": "TCGA-D1-A3DA-D41466",
    "bcr_drug_uuid": "A049BBCE-FA19-4CD6-B42C-6E49CDA1792C",
    "form_completion_date": "2015-5-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "07C805C2-FF09-4D5A-95F8-1D7D9F84C33C",
    "patient_ID": "TCGA.D1.A3JQ",
    "bcr_drug_barcode": "TCGA-D1-A3JQ-D41511",
    "bcr_drug_uuid": "CD25CB70-0A77-4D34-BA51-EDAC23F112FA",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "07C805C2-FF09-4D5A-95F8-1D7D9F84C33C",
    "patient_ID": "TCGA.D1.A3JQ",
    "bcr_drug_barcode": "TCGA-D1-A3JQ-D41514",
    "bcr_drug_uuid": "22AB22A1-0398-439A-ACAA-367AE01F9672",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "07C805C2-FF09-4D5A-95F8-1D7D9F84C33C",
    "patient_ID": "TCGA.D1.A3JQ",
    "bcr_drug_barcode": "TCGA-D1-A3JQ-D41414",
    "bcr_drug_uuid": "25EAB43E-3F2B-4849-84A0-C1EBB97A7104",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5BF97D66-CDC6-47D0-AC74-5C6280B31072",
    "patient_ID": "TCGA.DF.A2KY",
    "bcr_drug_barcode": "TCGA-DF-A2KY-D68285",
    "bcr_drug_uuid": "197CDE95-37EA-4C35-96A1-E2A7A2ECD2DA",
    "form_completion_date": "2014-11-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5BF97D66-CDC6-47D0-AC74-5C6280B31072",
    "patient_ID": "TCGA.DF.A2KY",
    "bcr_drug_barcode": "TCGA-DF-A2KY-D68287",
    "bcr_drug_uuid": "B7CCA72C-C50F-4C10-845D-0924A8668759",
    "form_completion_date": "2014-11-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7ADAF608-19A5-4184-8B79-BBC6F9CF24AE",
    "patient_ID": "TCGA.DF.A2L0",
    "bcr_drug_barcode": "TCGA-DF-A2L0-D49843",
    "bcr_drug_uuid": "7323A98C-6B53-4865-89D5-0144C3D6BA1C",
    "form_completion_date": "2013-10-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201
  },
  {
    "bcr_patient_uuid": "7ADAF608-19A5-4184-8B79-BBC6F9CF24AE",
    "patient_ID": "TCGA.DF.A2L0",
    "bcr_drug_barcode": "TCGA-DF-A2L0-D49844",
    "bcr_drug_uuid": "22677ECF-06A8-48BB-AD39-B0559A136CA1",
    "form_completion_date": "2013-10-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201
  },
  {
    "bcr_patient_uuid": "7ADAF608-19A5-4184-8B79-BBC6F9CF24AE",
    "patient_ID": "TCGA.DF.A2L0",
    "bcr_drug_barcode": "TCGA-DF-A2L0-D49845",
    "bcr_drug_uuid": "5E62BC04-62C5-40E4-A076-8747C405EF95",
    "form_completion_date": "2013-10-11",
    "pharmaceutical_therapy_drug_name": "CLINICAL TRIAL-STUDY AGENT",
    "days_to_drug_start": 565,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 607,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "53245616-e095-4616-89bb-6062669122da",
    "patient_ID": "TCGA.DI.A1BU",
    "bcr_drug_barcode": "TCGA-DI-A1BU-D20906",
    "bcr_drug_uuid": "E8C43E75-3E96-46E9-A2A3-F584F56B2D8A",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3550,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3550
  },
  {
    "bcr_patient_uuid": "53245616-e095-4616-89bb-6062669122da",
    "patient_ID": "TCGA.DI.A1BU",
    "bcr_drug_barcode": "TCGA-DI-A1BU-D20910",
    "bcr_drug_uuid": "547C2EF6-B61D-4381-91A7-CF0E9062878B",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "944a102f-3475-45aa-9e30-4b92d1449f00",
    "patient_ID": "TCGA.DI.A1NN",
    "bcr_drug_barcode": "TCGA-DI-A1NN-D19275",
    "bcr_drug_uuid": "E4429CA4-7B7D-44CB-A374-CFEBF5051355",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3070,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3070
  },
  {
    "bcr_patient_uuid": "944a102f-3475-45aa-9e30-4b92d1449f00",
    "patient_ID": "TCGA.DI.A1NN",
    "bcr_drug_barcode": "TCGA-DI-A1NN-D20763",
    "bcr_drug_uuid": "BD8B8E7B-0983-4774-91A1-0A0E84FA43AD",
    "form_completion_date": "2012-1-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1915,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1915
  },
  {
    "bcr_patient_uuid": "944a102f-3475-45aa-9e30-4b92d1449f00",
    "patient_ID": "TCGA.DI.A1NN",
    "bcr_drug_barcode": "TCGA-DI-A1NN-D20800",
    "bcr_drug_uuid": "79C8C499-8BAB-4EE3-A171-61A469BFE122",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "AZD6244",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1045,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1121,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "6524A6D3-A9F0-4A46-AC0B-7BEB0CD1B915",
    "patient_ID": "TCGA.DI.A2QY",
    "bcr_drug_barcode": "TCGA-DI-A2QY-D60674",
    "bcr_drug_uuid": "CA7FE5CE-C641-464F-AC82-7C12F0C3D39F",
    "form_completion_date": "2014-6-13",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9205c164-7975-421a-90c3-edfe8def595c",
    "patient_ID": "TCGA.E6.A1LZ",
    "bcr_drug_barcode": "TCGA-E6-A1LZ-D20256",
    "bcr_drug_uuid": "F9CDDFAE-6B75-4345-9786-426AA6419657",
    "form_completion_date": "2011-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 292,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1751
  },
  {
    "bcr_patient_uuid": "9205c164-7975-421a-90c3-edfe8def595c",
    "patient_ID": "TCGA.E6.A1LZ",
    "bcr_drug_barcode": "TCGA-E6-A1LZ-D20252",
    "bcr_drug_uuid": "D7EA3FC9-A234-45A6-82D7-B79EC820C9B2",
    "form_completion_date": "2011-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 467,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2735
  },
  {
    "bcr_patient_uuid": "e3dcde4e-5def-4b89-97b4-047b8288919b",
    "patient_ID": "TCGA.E6.A1M0",
    "bcr_drug_barcode": "TCGA-E6-A1M0-D19867",
    "bcr_drug_uuid": "704FF6AB-F05F-4CE7-AFB0-4E73824761C3",
    "form_completion_date": "2011-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3882
  },
  {
    "bcr_patient_uuid": "e3dcde4e-5def-4b89-97b4-047b8288919b",
    "patient_ID": "TCGA.E6.A1M0",
    "bcr_drug_barcode": "TCGA-E6-A1M0-D19866",
    "bcr_drug_uuid": "0BD93C40-2642-47CE-9189-0081CCBC4E50",
    "form_completion_date": "2011-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "EB642568-30D4-4805-A295-BDA314CCAAAF",
    "patient_ID": "TCGA.E6.A8L9",
    "bcr_drug_barcode": "TCGA-E6-A8L9-D58267",
    "bcr_drug_uuid": "DCF63FF7-75E5-4FEF-A592-9D9AB93B9049",
    "form_completion_date": "2014-4-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EB642568-30D4-4805-A295-BDA314CCAAAF",
    "patient_ID": "TCGA.E6.A8L9",
    "bcr_drug_barcode": "TCGA-E6-A8L9-D58266",
    "bcr_drug_uuid": "08FF35F7-8848-4C42-8ADE-A37D56A87028",
    "form_completion_date": "2014-4-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f17bb238-2651-48a5-9a47-5077218efe08",
    "patient_ID": "TCGA.EC.A1QX",
    "bcr_drug_barcode": "TCGA-EC-A1QX-D21079",
    "bcr_drug_uuid": "CA871009-3593-43C2-B74F-15C1BBB3894E",
    "form_completion_date": "2012-1-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "f17bb238-2651-48a5-9a47-5077218efe08",
    "patient_ID": "TCGA.EC.A1QX",
    "bcr_drug_barcode": "TCGA-EC-A1QX-D21082",
    "bcr_drug_uuid": "875BDC65-C7FA-487C-A6FB-14388FF8CC6A",
    "form_completion_date": "2012-1-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 570,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2280
  },
  {
    "bcr_patient_uuid": "f17bb238-2651-48a5-9a47-5077218efe08",
    "patient_ID": "TCGA.EC.A1QX",
    "bcr_drug_barcode": "TCGA-EC-A1QX-D21080",
    "bcr_drug_uuid": "27E211E2-58A4-413E-8487-4A5C7AA222E8",
    "form_completion_date": "2012-1-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6400
  },
  {
    "bcr_patient_uuid": "b5c1e511-baf2-45b3-9919-110e8941e3c2",
    "patient_ID": "TCGA.EC.A24G",
    "bcr_drug_barcode": "TCGA-EC-A24G-D31228",
    "bcr_drug_uuid": "20558686-C2CD-4834-9738-8E654AE46E3E",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "b5c1e511-baf2-45b3-9919-110e8941e3c2",
    "patient_ID": "TCGA.EC.A24G",
    "bcr_drug_barcode": "TCGA-EC-A24G-D31229",
    "bcr_drug_uuid": "F5733146-363B-4040-9D58-B0F462A4777F",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "b5c1e511-baf2-45b3-9919-110e8941e3c2",
    "patient_ID": "TCGA.EC.A24G",
    "bcr_drug_barcode": "TCGA-EC-A24G-D31231",
    "bcr_drug_uuid": "F9F2DE02-F608-409B-BD34-6E43FFFC76C6",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 550,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "b5c1e511-baf2-45b3-9919-110e8941e3c2",
    "patient_ID": "TCGA.EC.A24G",
    "bcr_drug_barcode": "TCGA-EC-A24G-D31233",
    "bcr_drug_uuid": "1FCDCEBA-3F70-4B21-9A6F-90DE0B048F05",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2160
  },
  {
    "bcr_patient_uuid": "b5c1e511-baf2-45b3-9919-110e8941e3c2",
    "patient_ID": "TCGA.EC.A24G",
    "bcr_drug_barcode": "TCGA-EC-A24G-D31226",
    "bcr_drug_uuid": "14917874-4E6B-4998-A0F3-C5207EFA2635",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "5f2f2e7a-8aec-4011-b261-0c5bc68da840",
    "patient_ID": "TCGA.EO.A1Y5",
    "bcr_drug_barcode": "TCGA-EO-A1Y5-D56548",
    "bcr_drug_uuid": "DE3D9B2C-395E-4336-B8D3-BF53D4A0AF1B",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f2f2e7a-8aec-4011-b261-0c5bc68da840",
    "patient_ID": "TCGA.EO.A1Y5",
    "bcr_drug_barcode": "TCGA-EO-A1Y5-D56549",
    "bcr_drug_uuid": "F1010094-972C-4393-8692-F13BF3DF4EA6",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "71ed2681-79bb-4ffb-985c-6d3cf18e9168",
    "patient_ID": "TCGA.EO.A1Y7",
    "bcr_drug_barcode": "TCGA-EO-A1Y7-D68568",
    "bcr_drug_uuid": "63F8D45C-03B7-4FC5-A46A-96C948E424A9",
    "form_completion_date": "2014-11-26",
    "pharmaceutical_therapy_drug_name": "PORTEC3-RADIATION ALONE",
    "clinical_trial_drug_classification": "RADIATION ALONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 911,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1031,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "10EB7DFA-D43D-479F-8C46-C0424207F958",
    "patient_ID": "TCGA.EO.A22X",
    "bcr_drug_barcode": "TCGA-EO-A22X-D39979",
    "bcr_drug_uuid": "E43618B8-4EA4-4509-88FE-96F6C6917847",
    "form_completion_date": "2013-2-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "10EB7DFA-D43D-479F-8C46-C0424207F958",
    "patient_ID": "TCGA.EO.A22X",
    "bcr_drug_barcode": "TCGA-EO-A22X-D39981",
    "bcr_drug_uuid": "FC7FC150-BE27-440E-9A6D-C267DB7A9EEA",
    "form_completion_date": "2013-2-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF363CEC-BEC9-4DE3-8CC2-E98B0EED2858",
    "patient_ID": "TCGA.EO.A2CG",
    "bcr_drug_barcode": "TCGA-EO-A2CG-D56881",
    "bcr_drug_uuid": "28646D52-41D7-48BD-AE33-873840D5ECAC",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF363CEC-BEC9-4DE3-8CC2-E98B0EED2858",
    "patient_ID": "TCGA.EO.A2CG",
    "bcr_drug_barcode": "TCGA-EO-A2CG-D56884",
    "bcr_drug_uuid": "9100F8AD-3D0F-433E-A172-B739230B7817",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CC9A11F-1AC4-431D-8F94-52A3BC02B572",
    "patient_ID": "TCGA.EO.A2CH",
    "bcr_drug_barcode": "TCGA-EO-A2CH-D56867",
    "bcr_drug_uuid": "A279CDF8-5A8C-4A2F-ADCF-6C0CC35047AD",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CC9A11F-1AC4-431D-8F94-52A3BC02B572",
    "patient_ID": "TCGA.EO.A2CH",
    "bcr_drug_barcode": "TCGA-EO-A2CH-D56868",
    "bcr_drug_uuid": "49824B45-BDBD-4464-B634-34EDF361FB2A",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CC9A11F-1AC4-431D-8F94-52A3BC02B572",
    "patient_ID": "TCGA.EO.A2CH",
    "bcr_drug_barcode": "TCGA-EO-A2CH-D56870",
    "bcr_drug_uuid": "EFD83836-6B57-413E-92BD-726D33E21538",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D383008A-A1BF-4689-B243-3C464C79B818",
    "patient_ID": "TCGA.EO.A3AV",
    "bcr_drug_barcode": "TCGA-EO-A3AV-D48631",
    "bcr_drug_uuid": "F45A33D2-7384-4E99-BE4A-28059BE1EC37",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D383008A-A1BF-4689-B243-3C464C79B818",
    "patient_ID": "TCGA.EO.A3AV",
    "bcr_drug_barcode": "TCGA-EO-A3AV-D56829",
    "bcr_drug_uuid": "32083A34-F5E9-41FF-A054-C6340A99ACBE",
    "form_completion_date": "2014-2-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2CF8DE9F-B305-4D98-BFD4-33377BF6138F",
    "patient_ID": "TCGA.EO.A3B1",
    "bcr_drug_barcode": "TCGA-EO-A3B1-D48643",
    "bcr_drug_uuid": "88CFF985-56F3-40FF-A124-978DEC024914",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2CF8DE9F-B305-4D98-BFD4-33377BF6138F",
    "patient_ID": "TCGA.EO.A3B1",
    "bcr_drug_barcode": "TCGA-EO-A3B1-D39920",
    "bcr_drug_uuid": "6657249F-7B31-4120-8EFC-520B52034B6E",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2CF8DE9F-B305-4D98-BFD4-33377BF6138F",
    "patient_ID": "TCGA.EO.A3B1",
    "bcr_drug_barcode": "TCGA-EO-A3B1-D56864",
    "bcr_drug_uuid": "0AD25756-99D7-4745-A7EF-084969E5B859",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB67A9CD-65BA-4D6F-A799-031B6B3DF599",
    "patient_ID": "TCGA.EO.A3KU",
    "bcr_drug_barcode": "TCGA-EO-A3KU-D39923",
    "bcr_drug_uuid": "D98C6197-DA67-4647-8ED6-579FA73D9AA8",
    "form_completion_date": "2013-2-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB67A9CD-65BA-4D6F-A799-031B6B3DF599",
    "patient_ID": "TCGA.EO.A3KU",
    "bcr_drug_barcode": "TCGA-EO-A3KU-D39924",
    "bcr_drug_uuid": "A8777E89-BE11-4650-8E25-F52619900C99",
    "form_completion_date": "2013-2-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB67A9CD-65BA-4D6F-A799-031B6B3DF599",
    "patient_ID": "TCGA.EO.A3KU",
    "bcr_drug_barcode": "TCGA-EO-A3KU-D48716",
    "bcr_drug_uuid": "F06DA8DF-9A22-473F-8E07-72C9FCD5E3AE",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F764AC1-3DE7-4CFD-A77A-D21BAA418834",
    "patient_ID": "TCGA.EO.A3KW",
    "bcr_drug_barcode": "TCGA-EO-A3KW-D39970",
    "bcr_drug_uuid": "0405EE3C-0A59-4252-B7EC-09B11D075D7A",
    "form_completion_date": "2013-2-7",
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "1a094c2b-9fba-4bb1-929d-bb2cdf874bee",
    "patient_ID": "TCGA.EY.A1GM",
    "bcr_drug_barcode": "TCGA-EY-A1GM-D11894",
    "bcr_drug_uuid": "236e44ec-7cf8-43c7-bc29-2ce84ee417ab",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "1a094c2b-9fba-4bb1-929d-bb2cdf874bee",
    "patient_ID": "TCGA.EY.A1GM",
    "bcr_drug_barcode": "TCGA-EY-A1GM-D11891",
    "bcr_drug_uuid": "dec72b13-2260-4b4d-95fc-51d6f67fca9d",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1830
  },
  {
    "bcr_patient_uuid": "9370e189-8fb7-4bfa-8ef9-2220f3557188",
    "patient_ID": "TCGA.EY.A1GO",
    "bcr_drug_barcode": "TCGA-EY-A1GO-D11907",
    "bcr_drug_uuid": "729a7e33-febc-46ad-b80d-ae5dd18b6140",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9370e189-8fb7-4bfa-8ef9-2220f3557188",
    "patient_ID": "TCGA.EY.A1GO",
    "bcr_drug_barcode": "TCGA-EY-A1GO-D12158",
    "bcr_drug_uuid": "07233b50-779a-4ac0-a22c-83c53bf29b4a",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9370e189-8fb7-4bfa-8ef9-2220f3557188",
    "patient_ID": "TCGA.EY.A1GO",
    "bcr_drug_barcode": "TCGA-EY-A1GO-D19762",
    "bcr_drug_uuid": "1CC58041-7B97-4C36-9342-7D244E243B76",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 552,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8636db4d-a67b-4d8a-b02f-15fce553cf17",
    "patient_ID": "TCGA.EY.A1GQ",
    "bcr_drug_barcode": "TCGA-EY-A1GQ-D13193",
    "bcr_drug_uuid": "AD01F405-B135-4E73-A0A4-2DC254E4F2B3",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8636db4d-a67b-4d8a-b02f-15fce553cf17",
    "patient_ID": "TCGA.EY.A1GQ",
    "bcr_drug_barcode": "TCGA-EY-A1GQ-D13195",
    "bcr_drug_uuid": "CDF252A5-E73A-4267-8CF5-047C3262933E",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c10b2885-70ea-4d32-bc48-8b85530df702",
    "patient_ID": "TCGA.EY.A1GS",
    "bcr_drug_barcode": "TCGA-EY-A1GS-D11994",
    "bcr_drug_uuid": "5e83ae05-6360-4b62-93e4-c587d3060795",
    "form_completion_date": "2011-5-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2660
  },
  {
    "bcr_patient_uuid": "c10b2885-70ea-4d32-bc48-8b85530df702",
    "patient_ID": "TCGA.EY.A1GS",
    "bcr_drug_barcode": "TCGA-EY-A1GS-D12000",
    "bcr_drug_uuid": "674e26a2-46f4-4864-9c1c-1dd6228b72f4",
    "form_completion_date": "2011-5-19",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "REFRACTORY NEUTROPENIA & THROMPOCYTOPENIA"
  },
  {
    "bcr_patient_uuid": "c10b2885-70ea-4d32-bc48-8b85530df702",
    "patient_ID": "TCGA.EY.A1GS",
    "bcr_drug_barcode": "TCGA-EY-A1GS-D11999",
    "bcr_drug_uuid": "7f532712-d88d-4245-82a5-26d24b6a4155",
    "form_completion_date": "2011-5-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "e0d13e2d-cf48-4b66-bfc2-88f872f67d79",
    "patient_ID": "TCGA.EY.A1GT",
    "bcr_drug_barcode": "TCGA-EY-A1GT-D12163",
    "bcr_drug_uuid": "5b3bc832-1171-4cb2-b4f1-e40b88f91bc0",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e0d13e2d-cf48-4b66-bfc2-88f872f67d79",
    "patient_ID": "TCGA.EY.A1GT",
    "bcr_drug_barcode": "TCGA-EY-A1GT-D12161",
    "bcr_drug_uuid": "70d61107-e630-4f30-963f-13c47c0321a3",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3e39474-c2b0-45af-bbe1-4c24f17cc284",
    "patient_ID": "TCGA.EY.A1GV",
    "bcr_drug_barcode": "TCGA-EY-A1GV-D12142",
    "bcr_drug_uuid": "14af89d6-5339-4892-b5ea-b5177b2d121e",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3615
  },
  {
    "bcr_patient_uuid": "e3e39474-c2b0-45af-bbe1-4c24f17cc284",
    "patient_ID": "TCGA.EY.A1GV",
    "bcr_drug_barcode": "TCGA-EY-A1GV-D12144",
    "bcr_drug_uuid": "68408952-e0ee-4a9a-943e-4fd66c106a1e",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1915
  },
  {
    "bcr_patient_uuid": "f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae",
    "patient_ID": "TCGA.EY.A1GW",
    "bcr_drug_barcode": "TCGA-EY-A1GW-D12149",
    "bcr_drug_uuid": "7478aefe-6872-483e-ae4d-cb313be0a66d",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2560
  },
  {
    "bcr_patient_uuid": "f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae",
    "patient_ID": "TCGA.EY.A1GW",
    "bcr_drug_barcode": "TCGA-EY-A1GW-D12150",
    "bcr_drug_uuid": "5E6AAECB-7749-486C-BBB2-EE4E1FDD8ADC",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 131,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1425
  },
  {
    "bcr_patient_uuid": "f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae",
    "patient_ID": "TCGA.EY.A1GW",
    "bcr_drug_barcode": "TCGA-EY-A1GW-D12153",
    "bcr_drug_uuid": "FA16930B-93D5-45F7-A5FC-98702C2DDF69",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c71e0986-56c0-45f4-be8d-2236e4418604",
    "patient_ID": "TCGA.EY.A1H0",
    "bcr_drug_barcode": "TCGA-EY-A1H0-D11987",
    "bcr_drug_uuid": "6e8c5668-6e62-4e1f-9da3-0d93afd8010f",
    "form_completion_date": "2011-5-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3380
  },
  {
    "bcr_patient_uuid": "c71e0986-56c0-45f4-be8d-2236e4418604",
    "patient_ID": "TCGA.EY.A1H0",
    "bcr_drug_barcode": "TCGA-EY-A1H0-D11991",
    "bcr_drug_uuid": "1949bcfd-ed02-496e-85ec-e12b67d33a98",
    "form_completion_date": "2011-5-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1660
  },
  {
    "bcr_patient_uuid": "c71e0986-56c0-45f4-be8d-2236e4418604",
    "patient_ID": "TCGA.EY.A1H0",
    "bcr_drug_barcode": "TCGA-EY-A1H0-D19895",
    "bcr_drug_uuid": "52D36843-476C-4FE2-94D2-63C0852748C5",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT LAD"
  },
  {
    "bcr_patient_uuid": "4125e3e5-51c0-4577-9935-10cd086fc415",
    "patient_ID": "TCGA.EY.A214",
    "bcr_drug_barcode": "TCGA-EY-A214-D21728",
    "bcr_drug_uuid": "5FF2B3F3-9507-4DBF-BF8A-4FA73A239E67",
    "form_completion_date": "2012-2-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4125e3e5-51c0-4577-9935-10cd086fc415",
    "patient_ID": "TCGA.EY.A214",
    "bcr_drug_barcode": "TCGA-EY-A214-D13686",
    "bcr_drug_uuid": "B331A48C-AD2B-4B63-B581-0C28B1F9C030",
    "form_completion_date": "2012-2-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2B60EF45-336C-42E0-AA3F-577069310D1F",
    "patient_ID": "TCGA.EY.A2OM",
    "bcr_drug_barcode": "TCGA-EY-A2OM-D18362",
    "bcr_drug_uuid": "2A7281C8-9508-4FE2-9CD3-C8B3948DB8B5",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2B60EF45-336C-42E0-AA3F-577069310D1F",
    "patient_ID": "TCGA.EY.A2OM",
    "bcr_drug_barcode": "TCGA-EY-A2OM-D18363",
    "bcr_drug_uuid": "2CBF5E14-5D00-4BEB-B905-23DDDA6D38C0",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A",
    "patient_ID": "TCGA.EY.A2ON",
    "bcr_drug_barcode": "TCGA-EY-A2ON-D34165",
    "bcr_drug_uuid": "347ECDE5-07E3-406D-B5B8-38374BC3211B",
    "form_completion_date": "2012-7-31",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A",
    "patient_ID": "TCGA.EY.A2ON",
    "bcr_drug_barcode": "TCGA-EY-A2ON-D34166",
    "bcr_drug_uuid": "FC059943-BA02-4E02-B2C9-3A8222FB859F",
    "form_completion_date": "2012-7-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A",
    "patient_ID": "TCGA.EY.A2ON",
    "bcr_drug_barcode": "TCGA-EY-A2ON-D34167",
    "bcr_drug_uuid": "927F964B-C56F-4273-BBB8-5E8F6E940535",
    "form_completion_date": "2012-7-31",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 352,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A",
    "patient_ID": "TCGA.EY.A2ON",
    "bcr_drug_barcode": "TCGA-EY-A2ON-D34168",
    "bcr_drug_uuid": "9639F926-E6DA-4DDA-BAEC-BFDBBF9BC9E7",
    "form_completion_date": "2012-7-31",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 373,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "068016E2-7829-493C-B8BE-D3B85BEAAB13",
    "patient_ID": "TCGA.EY.A2OO",
    "bcr_drug_barcode": "TCGA-EY-A2OO-D18377",
    "bcr_drug_uuid": "4DD1C41D-81D8-4798-9DF2-D4185E7AAAE9",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "068016E2-7829-493C-B8BE-D3B85BEAAB13",
    "patient_ID": "TCGA.EY.A2OO",
    "bcr_drug_barcode": "TCGA-EY-A2OO-D18376",
    "bcr_drug_uuid": "F3F452D5-1549-4D94-80BF-6AF749480881",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "06728B1B-6B69-4467-8E10-A8A4E6328AC8",
    "patient_ID": "TCGA.EY.A3L3",
    "bcr_drug_barcode": "TCGA-EY-A3L3-D38201",
    "bcr_drug_uuid": "6AC34DE1-0DA4-4121-92C8-4D606A4150A0",
    "form_completion_date": "2012-12-11",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "06728B1B-6B69-4467-8E10-A8A4E6328AC8",
    "patient_ID": "TCGA.EY.A3L3",
    "bcr_drug_barcode": "TCGA-EY-A3L3-D38202",
    "bcr_drug_uuid": "4247ED11-E833-438D-89A6-7034E5B9E95C",
    "form_completion_date": "2012-12-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "8BB89C0F-0F04-485E-8E08-801042DFCBA9",
    "patient_ID": "TCGA.EY.A3QX",
    "bcr_drug_barcode": "TCGA-EY-A3QX-D40909",
    "bcr_drug_uuid": "A93B97A0-7966-4862-9959-9799991D54BE",
    "form_completion_date": "2013-3-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8BB89C0F-0F04-485E-8E08-801042DFCBA9",
    "patient_ID": "TCGA.EY.A3QX",
    "bcr_drug_barcode": "TCGA-EY-A3QX-D40910",
    "bcr_drug_uuid": "E3193309-538E-46AF-8042-6D6D5F2B1A62",
    "form_completion_date": "2013-3-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DF27B584-FA45-4A8F-BD12-A018CC63DCA1",
    "patient_ID": "TCGA.EY.A4KR",
    "bcr_drug_barcode": "TCGA-EY-A4KR-D44428",
    "bcr_drug_uuid": "A9344829-A816-4F95-AEA0-B6915253259D",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DF27B584-FA45-4A8F-BD12-A018CC63DCA1",
    "patient_ID": "TCGA.EY.A4KR",
    "bcr_drug_barcode": "TCGA-EY-A4KR-D44496",
    "bcr_drug_uuid": "D85A2FDB-3A08-413C-B014-3B84DEB10D72",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75783DBE-E18C-4535-B9EB-2AFFD320E098",
    "patient_ID": "TCGA.EY.A54A",
    "bcr_drug_barcode": "TCGA-EY-A54A-D44463",
    "bcr_drug_uuid": "252913A3-F113-4639-9090-7C5697D1DE80",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75783DBE-E18C-4535-B9EB-2AFFD320E098",
    "patient_ID": "TCGA.EY.A54A",
    "bcr_drug_barcode": "TCGA-EY-A54A-D44464",
    "bcr_drug_uuid": "A18E520C-8948-498F-A4AB-1E1F8A239299",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B9AB4AB9-BA9C-4A01-9F61-55C82B924936",
    "patient_ID": "TCGA.FI.A2CY",
    "bcr_drug_barcode": "TCGA-FI-A2CY-D31802",
    "bcr_drug_uuid": "67056E36-2999-4086-9004-ACE65EE6B379",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B9AB4AB9-BA9C-4A01-9F61-55C82B924936",
    "patient_ID": "TCGA.FI.A2CY",
    "bcr_drug_barcode": "TCGA-FI-A2CY-D31803",
    "bcr_drug_uuid": "6569B8F9-F06F-486A-9A27-5B84CD316932",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B9AB4AB9-BA9C-4A01-9F61-55C82B924936",
    "patient_ID": "TCGA.FI.A2CY",
    "bcr_drug_barcode": "TCGA-FI-A2CY-D31804",
    "bcr_drug_uuid": "AB47B1E1-C904-4EF0-BCF5-0EC7EE6FA257",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "46A1FDB9-548D-44D1-AB77-D51D44AC8198",
    "patient_ID": "TCGA.FI.A2D2",
    "bcr_drug_barcode": "TCGA-FI-A2D2-D31805",
    "bcr_drug_uuid": "0BF2296A-8A54-4506-9A83-20546DE55E9D",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "46A1FDB9-548D-44D1-AB77-D51D44AC8198",
    "patient_ID": "TCGA.FI.A2D2",
    "bcr_drug_barcode": "TCGA-FI-A2D2-D31806",
    "bcr_drug_uuid": "1ABE5B06-85E2-4848-91D4-A94B3BE8D219",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "490AE247-EE67-48D4-94ED-93DF5B9BBEFE",
    "patient_ID": "TCGA.FI.A2D4",
    "bcr_drug_barcode": "TCGA-FI-A2D4-D31807",
    "bcr_drug_uuid": "5A0D5B78-FE7E-4707-9DDF-1B0A94D7C029",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "490AE247-EE67-48D4-94ED-93DF5B9BBEFE",
    "patient_ID": "TCGA.FI.A2D4",
    "bcr_drug_barcode": "TCGA-FI-A2D4-D31808",
    "bcr_drug_uuid": "204FA8FE-18AB-494E-9753-516BC392720D",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCFBE781-A92A-45B5-B80A-E3BB3BDC0D9A",
    "patient_ID": "TCGA.FI.A2D5",
    "bcr_drug_barcode": "TCGA-FI-A2D5-D31762",
    "bcr_drug_uuid": "D94E793F-5F81-4E18-8650-783FE58AEEBC",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCFBE781-A92A-45B5-B80A-E3BB3BDC0D9A",
    "patient_ID": "TCGA.FI.A2D5",
    "bcr_drug_barcode": "TCGA-FI-A2D5-D31763",
    "bcr_drug_uuid": "5BEBBD5C-0735-41BE-B369-1E10A0DEE1EE",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4284A85D-D9B6-40EE-AAC4-C2C03554528E",
    "patient_ID": "TCGA.FI.A2EU",
    "bcr_drug_barcode": "TCGA-FI-A2EU-D31786",
    "bcr_drug_uuid": "EE97F906-C5C8-4EAE-BE16-D0C1EA923337",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4284A85D-D9B6-40EE-AAC4-C2C03554528E",
    "patient_ID": "TCGA.FI.A2EU",
    "bcr_drug_barcode": "TCGA-FI-A2EU-D31788",
    "bcr_drug_uuid": "AD5397A3-A6C7-477F-9AF6-D7B0F7F1B025",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1971,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31789",
    "bcr_drug_uuid": "9A7D7BC1-0B90-4A85-BD13-ABEE0E29153F",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31790",
    "bcr_drug_uuid": "6A220731-BF58-4BA0-8456-EC0FBC280442",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31791",
    "bcr_drug_uuid": "55689775-DD6B-4E9C-AB00-8D75A39A5FBE",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1273,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31792",
    "bcr_drug_uuid": "656C3B13-C073-42F4-AAA0-DCE9720F4DA2",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1273,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31793",
    "bcr_drug_uuid": "AF6163E1-112C-4EC7-8224-1446635F13AC",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1326,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F",
    "patient_ID": "TCGA.FI.A2EW",
    "bcr_drug_barcode": "TCGA-FI-A2EW-D31794",
    "bcr_drug_uuid": "0F405948-4CF7-4038-BD75-514E94F070D1",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1369,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1431,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3878F58E-76BA-4480-A784-88505BD464D0",
    "patient_ID": "TCGA.FI.A2EX",
    "bcr_drug_barcode": "TCGA-FI-A2EX-D31795",
    "bcr_drug_uuid": "0ECA6508-11F3-42A7-9CB3-5872F1461881",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3878F58E-76BA-4480-A784-88505BD464D0",
    "patient_ID": "TCGA.FI.A2EX",
    "bcr_drug_barcode": "TCGA-FI-A2EX-D31796",
    "bcr_drug_uuid": "B72831D6-8FC8-45BB-BABD-47AA4035A915",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3878F58E-76BA-4480-A784-88505BD464D0",
    "patient_ID": "TCGA.FI.A2EX",
    "bcr_drug_barcode": "TCGA-FI-A2EX-D31797",
    "bcr_drug_uuid": "91F83297-BCB4-494C-AEF1-8B31AEB3E31A",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "787C3E2F-A708-4985-A5B1-B2383C7BFC52",
    "patient_ID": "TCGA.FI.A2EY",
    "bcr_drug_barcode": "TCGA-FI-A2EY-D31800",
    "bcr_drug_uuid": "97048882-64BE-4634-8361-2DCF7360D631",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "787C3E2F-A708-4985-A5B1-B2383C7BFC52",
    "patient_ID": "TCGA.FI.A2EY",
    "bcr_drug_barcode": "TCGA-FI-A2EY-D31801",
    "bcr_drug_uuid": "07DFD2BF-B19E-4F1A-9FA2-5850FA9EBB56",
    "form_completion_date": "2012-5-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "601734DA-2D11-4745-A260-0965F58AADEA",
    "patient_ID": "TCGA.FI.A2F8",
    "bcr_drug_barcode": "TCGA-FI-A2F8-D31810",
    "bcr_drug_uuid": "26AA6385-BECF-40CF-98C0-6CC43F3B50E3",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "601734DA-2D11-4745-A260-0965F58AADEA",
    "patient_ID": "TCGA.FI.A2F8",
    "bcr_drug_barcode": "TCGA-FI-A2F8-D31812",
    "bcr_drug_uuid": "BFAD841D-D24F-4BFB-ABB1-429765A427E2",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "601734DA-2D11-4745-A260-0965F58AADEA",
    "patient_ID": "TCGA.FI.A2F8",
    "bcr_drug_barcode": "TCGA-FI-A2F8-D31813",
    "bcr_drug_uuid": "66CA2923-6C4F-4545-B9AB-26EF42D42C0E",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E41CF2F-3DE9-44C1-A819-BCE693BAF67D",
    "patient_ID": "TCGA.JU.AAVI",
    "bcr_drug_barcode": "TCGA-JU-AAVI-D70308",
    "bcr_drug_uuid": "224D054E-7814-473D-94B6-1D2BC4FE3A8F",
    "form_completion_date": "2015-2-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E41CF2F-3DE9-44C1-A819-BCE693BAF67D",
    "patient_ID": "TCGA.JU.AAVI",
    "bcr_drug_barcode": "TCGA-JU-AAVI-D70309",
    "bcr_drug_uuid": "7AB9497C-682E-425B-875B-03613689F3C6",
    "form_completion_date": "2015-2-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E41CF2F-3DE9-44C1-A819-BCE693BAF67D",
    "patient_ID": "TCGA.JU.AAVI",
    "bcr_drug_barcode": "TCGA-JU-AAVI-D70310",
    "bcr_drug_uuid": "C21C33C8-19B3-4335-907F-69C1D6E90A29",
    "form_completion_date": "2015-2-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6303A05-F705-4413-8860-506A105D5B08",
    "patient_ID": "TCGA.K6.A3WQ",
    "bcr_drug_barcode": "TCGA-K6-A3WQ-D55415",
    "bcr_drug_uuid": "3E091F6E-431A-41CE-8BA6-2BD2F1019460",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6303A05-F705-4413-8860-506A105D5B08",
    "patient_ID": "TCGA.K6.A3WQ",
    "bcr_drug_barcode": "TCGA-K6-A3WQ-D55416",
    "bcr_drug_uuid": "97C33104-EC6B-43C8-B214-D8F152E9C9EF",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6303A05-F705-4413-8860-506A105D5B08",
    "patient_ID": "TCGA.K6.A3WQ",
    "bcr_drug_barcode": "TCGA-K6-A3WQ-D55417",
    "bcr_drug_uuid": "D9AF43C7-3058-413B-B3FB-1A84F061BAAD",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6303A05-F705-4413-8860-506A105D5B08",
    "patient_ID": "TCGA.K6.A3WQ",
    "bcr_drug_barcode": "TCGA-K6-A3WQ-D59159",
    "bcr_drug_uuid": "7E7328C4-4491-418F-9DB0-4C9AEBECC350",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A36D5DE-A097-4323-90E9-F1B924A8A5D8",
    "patient_ID": "TCGA.KJ.A3U4",
    "bcr_drug_barcode": "TCGA-KJ-A3U4-D71042",
    "bcr_drug_uuid": "8BF81D92-C201-4E9C-8D93-2D4B5BAD88EC",
    "form_completion_date": "2015-3-18",
    "pharmaceutical_therapy_drug_name": "LETROZOLE FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1033,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4ADC20D7-5AF1-4126-9073-C7D7AE465D92",
    "patient_ID": "TCGA.PG.A7D5",
    "bcr_drug_barcode": "TCGA-PG-A7D5-D71180",
    "bcr_drug_uuid": "68197989-E32B-4A6C-A219-5BA4C19502DB",
    "form_completion_date": "2015-3-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN/PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DF15901C-2508-42C9-BF06-026EFD89E51F",
    "patient_ID": "TCGA.QF.A5YS",
    "bcr_drug_barcode": "TCGA-QF-A5YS-D44656",
    "bcr_drug_uuid": "F05BDE3B-51A8-49E1-B6B0-13A9A1751181",
    "form_completion_date": "2013-6-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DF15901C-2508-42C9-BF06-026EFD89E51F",
    "patient_ID": "TCGA.QF.A5YS",
    "bcr_drug_barcode": "TCGA-QF-A5YS-D59671",
    "bcr_drug_uuid": "9DE9F15C-7959-409E-8578-60E6B608576C",
    "form_completion_date": "2014-5-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E4BCCEA0-0104-40C4-9E3C-2AD7262D918E",
    "patient_ID": "TCGA.QF.A5YT",
    "bcr_drug_barcode": "TCGA-QF-A5YT-D44676",
    "bcr_drug_uuid": "975570DE-DBC9-4A2B-B9E4-1C2E973DA609",
    "form_completion_date": "2013-6-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03381D49-E25F-4376-8E36-F47063A7D3FB",
    "patient_ID": "TCGA.QS.A5YQ",
    "bcr_drug_barcode": "TCGA-QS-A5YQ-D43117",
    "bcr_drug_uuid": "1CE4A515-1824-497A-89E9-42F23FF07160",
    "form_completion_date": "2013-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "03381D49-E25F-4376-8E36-F47063A7D3FB",
    "patient_ID": "TCGA.QS.A5YQ",
    "bcr_drug_barcode": "TCGA-QS-A5YQ-D43752",
    "bcr_drug_uuid": "1DF21841-4223-43CF-8F89-A8669026CC02",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "03381D49-E25F-4376-8E36-F47063A7D3FB",
    "patient_ID": "TCGA.QS.A5YQ",
    "bcr_drug_barcode": "TCGA-QS-A5YQ-D43753",
    "bcr_drug_uuid": "DB80D6EC-BF5B-46C0-9DA9-B9605C3ECC42",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "8E8F19BD-DBAA-4738-BAD2-207F634CD63D",
    "patient_ID": "TCGA.QS.A744",
    "bcr_drug_barcode": "TCGA-QS-A744-D51191",
    "bcr_drug_uuid": "4C944D25-528F-49A9-93AB-CAEAA3B5C66A",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8E8F19BD-DBAA-4738-BAD2-207F634CD63D",
    "patient_ID": "TCGA.QS.A744",
    "bcr_drug_barcode": "TCGA-QS-A744-D51192",
    "bcr_drug_uuid": "79CBB4E7-B1A5-4C8A-936B-8BFFD0E2CEE8",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54AC877A-52FF-450C-9DF9-B7CD3FC8E2E2",
    "patient_ID": "TCGA.QS.A8F1",
    "bcr_drug_barcode": "TCGA-QS-A8F1-D56573",
    "bcr_drug_uuid": "9B0EF2CF-5213-4B9B-8272-5A0ACEBD4A63",
    "form_completion_date": "2014-2-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "54AC877A-52FF-450C-9DF9-B7CD3FC8E2E2",
    "patient_ID": "TCGA.QS.A8F1",
    "bcr_drug_barcode": "TCGA-QS-A8F1-D56575",
    "bcr_drug_uuid": "0328D2CB-143C-4018-8CA4-B8DCF60930B7",
    "form_completion_date": "2014-2-13",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
